Tor Paaske Utheim

Bilde av Tor Paaske Utheim
English version of this page
Telefon +47-22840318
Brukernavn
Besøksadresse E-mail for fast replies: utheim2@gmail.com
Postadresse Postboks 1052 Blindern 0316 OSLO

Summary

Awards/honors: 24 (6 related to innovation)
Additional awards/honours based on co-author contributions: 10
Supervision of PhD-candidates as main or co-supervisor: 20 (13 current; 7 past)
Supervision of medical research students (3-years research program): 16 (12 current; 3 past; main supervisor for 11; co-supervisor for 4)
Supervision of dental research students (3-year research programme): (4 current, co-supervisor)
Supervision of medical students (master`s thesis/3-months research projects): 13 (6 current; 7 past; 11 main supervisor; 2 co-supervisor)
National and international invited talks: about 100
Publications or submitted manuscripts in peer-reviewed journals: >110 (a total of 33 last authorships; 52 peer-reviewed papers since January 2016)
Abstracts: 175
Patent applications: 6
Companies established: 6
Current positions related to research and/or innovation: 15
Current professorships (full): 4
External funding as project leader or project collaborator since 2004: $22 million.
Main academic achievements:
4 professorships; Harvard Medical School faculty member (since 2013); together with my research group, recipient of the largest innovation prize related to health care in Norway (Medinnova’s Innovation Award of $33,000 based on stem cell research); winner of the European Society of Ophthalmology Award for most promising Norwegian Young Clinician/Researcher; recipient of the Oslo University Hospital Early Career Award for outstanding research ($20,000);  an EU grant (2017) of $5 million (consortium member), and a Norwegian Research Council grant (2017) of $1.3 million (principal investigator)

Academic Background and Main Positions:

2018 - present President, Oslo Society of Ophthalmology (established 1905), Oslo, Norway
2018 - present Professor of Innovation, Department of Research and Development, Oslo Metropolitan University, Oslo, Norway
2018 - present Head, Unit for research-based innovation, Division of Head, Neck and Reconstructive Surgery, Oslo University Hospital, Oslo, Norway
2017 - present Professor, Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway
2017 - present President, Oslo Society of Ophthalmology, Oslo, Norway
2017 - present Director of Innovation/Senior Consultant/Senior Scientist, Department of Ophthalmology, Stavanger University Hospital
2017 - present Director of Research/Director of Innovation/Senior Consultant, Department of Ophthalmology, Arendal Hospital
2017 - present Senior Scientist, Department of Maxillofacial Surgery, Oslo University Hospital, Norway
2017 - present Senior Consultant, Mobilize Strategy Consulting, Oslo, Norway
2016 – present Director of Innovation, Division of Head, Neck and Reconstructive Surgery, Oslo University Hospital, Norway
2016 – present Senior Scientist, Department of Plastic and Reconstructive Surgery, Oslo University Hospital, Norway
2016 – present Senior Consultant/Senior Scientist, Department of Ophthalmology, Oslo University Hospital, Norway
2016 – present Professor (since 2016) and Head of Electron Microscopy lab (since 2014), Department of Oral Biology, Faculty of Dentistry, University of Oslo, Norway
2016 – present Editor-in-Chief, Oftalmolog (Nordic journal of ophthalmology)
2015 – present Professor, Department of Optometry and Visual Science/National Centre for Optics, Vision and Eye Care, Faculty of Health Sciences,University College of Southeast Norway
2015 – present Director of Research/Senior Consultant, Department of Ophthalmology, Drammen Hospital, Drammen, Norway
2015 – present Director of Research, the Norwegian Dry Eye Clinic, Oslo/Fredrikstad/Tromsø, Norway
2014 – present Head of Unit of Regenerative Medicine, Department of Medical Biochemistry, Oslo University Norway Hospital
2013– present Adjunct Clinical Associate, Schepens Eye Research Institute/Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, U.S (appointed Faculty Member in December 2013)
2015 – 2017 Vice President for the Norwegian Society of Ophthalmology
2015 - 2016 Director of Innovation, Oslo University Hospital, Norway (one-year engagement)
2014 -  2015 Associate Professor/Head of EM-lab, Department of Oral Biology, Faculty of Dentistry, University of Oslo, Norway
2014 Visiting Scientist, Schepens Eye Research Institute, Massachusetts Eye and Ear,
Department of Ophthalmology, Harvard Medical School, Boston, U.S (two months)
2013 - 2014 Acting Group Leader at the Unit of Regenerative Medicine, Department of Medical Biochemistry, Oslo University Hospital
2012 - 2013 Fulbright Visiting Scholar at Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, U.S.
2012 - 2013 Director of Research at the Dry Eye Clinic, Oslo, Norway
2012 - 2013 Chief Executive Officer for SynsLaser in Oslo and Tromsø, Norway
2011 Ophthalmologist (completed the five-year training program at the Department of Ophthalmology, Oslo University Hospital)
2011 Senior Research Fellow at Department of Medical Biochemistry, Oslo University Hospital
2010 Philosophia Doctor (PhD), "Novel technology in regenerative medicine: Eye bank storage of limbal explant cultures for transplantation"
2010 Chief Scientific Officer of Regena Medical AS, Norway
2009 Director of Research for Ophthalmology, Inven2, Oslo University Hospital
2009 Guest Scientist at Kyoto Prefectural University of Medicine, Japan
2008 Visiting Scientist at Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School Boston, US
2007 - 2011 Resident in Ophthalmology (with a few short leaves of absence due to research or innovation projects, the longest being six months as a consequence of an invitation to Harvard Medical School in 2008)
2005 - 2007 Lecturer/PhD candidate
2004 - 2005 Resident in Ophthalmology
2003 - 2004 University Lecturer, Oslo University Hospital, Rikshospitalet/Oslo
2001 Doctor of Medicine (MD) (laudabilis), University of Oslo, Norway

Supervisor Experiences (in total: 56 scientists):

Main supervisor: 9 PhD candidates (6 of whom have defended their theses: Jon Roger Eidet, Catherine Jackson, Rakibul Islam, Xiangjun Chen, and Aleksandar Stojanovic, Lara Pasovic. In addition, Øygunn Aass Utheim has submitted her thesis)
Co-supervisor: 12 PhD candidates (one of whom has defended her thesis: Ida Fostad. In addition, Peder Aabel has submitted his thesis)
Supervisor: 15 medical research students at the Faculty of Medicine, University of Oslo (1 year full-time and 2-year part-time research). The first student (Lara Pasovic) has 8 publications and 2 patent applications and defended her medical research thesis on November 25, 2015. Another five students, Marlen Parissi, Marit Lippestad, Adil Yasin, Nora Botten, Jiaxin Xiao, have defended their theses
Supervisor: 4 research students at the Faculty of Dentistry, University of Oslo (1-year full-time and 2-year part-time research)
Supervisor: 3 postdoctoral fellows
Main supervisor: 12 medical students (3-month research program, University of Oslo). A digital publication at the University of Oslo is the aim of this research program. The studies performed by the students are formally listed as master’s theses by the University of Oslo. Seven students so far have completed the program
Co-supervisor: 2 master’s students at the Faculty of Dentistry, University of Oslo; and Master’s Program in International Health Policy, University College in Oslo and Akershus

Awards/Honours (24):

2017: Short Term Scientific Mission Scholarship, European Cooperation in Science and Technology under the Seventh Framework Programme (FP7), 2017.
2017: Oslo University Hospital Early Career Award for Outstanding Research. Prize money NOK 150.000. Evaluation criteria: 1) Maximum 8 years of experience since completion of PhD and scientific track record showing great promise (any age); and 2) scientific excellence, i.e: peer review evaluation of scientific quality and impact. The international evaluation committee was led by Professor Sten Lindahl, Karolinska Institutet. Lindahl has previously served as chairman for the Nobel Prize Committee for Physiology or Medicine
2015: Søren Holths Award (includes prize money) for best presentation skills evaluated over the past two years, Norwegian Society of Ophthalmology (first time the award was given since 2005)
2016: Innovator of the Month, South-Eastern Norway Regional Health Authority, January 2016
2015: Outstanding Reviewer Award (Nanomedicine: Nanotechnology, Biology, and Medicine, Elsevier 5-year Impact Factor: 7.3)
2015: Scholarship for the European Leadership Development Programme (2015-2017)
2014: Travel Award by Oslo University Hospital to Harvard Medical School
2014: Scholarship to attend a course, equivalent to 1/3 of a master`s degree, on innovation in collaboration with the Norwegian Business School; Berkley, University of California, CA; and Stanford University, CA (selected by the Norwegian Research Council based on an ongoing innovation project in competition with innovation projects from a variety of disciplines, including IT, agriculture, oil industry, and medicine). Three selected from Oslo University Hospital for the Scholarship, whereof two were from my research group.
2014: Best Poster Award (2nd European Conference on Aniridia, Venice, Italy)
2013: Alcon Research Prize in Ophthalmology
2013: Travel Award by Oslo University Hospital to Harvard Medical School
2013: Lecturer Travel Award (sponsored in part by the U.S. Department of State)
2012: Fulbright Visiting Scholarship to Harvard University (14 months), sponsored in part by the U.S. Department of State
2012: Most Promising Young Clinician/ Researcher Award resulting in the European Society of Ophthalmology (SOE) Lecturer Award, National Society of Ophthalmology, November 2012.
2012: Travel Award by Oslo University Hospital to Harvard Medical School
2010: DNB Innovation Prize (finalist in Oslo)
2009: Director`s Award for Excellent Research, Oslo University Hospital, Ullevål
2008: Best Poster Award, Nordic Congress of Ophthalmology
2008: First prize winner of the Medinnova Innovation Competition, which is the largest innovation prize in health care in Norway (prize money NOK 250.000 - shared with members of the research group)
2007: Second prize winner of the Medinnova Innovation Competition
2001: The Voluntary International Medical Exam - first prize winner among University of Oslo students. The award and prize money were received at a ceremony at the University Aula in Oslo, Norway, November 21, 2001
1995: Best overall score of all time when graduating from high school. The score resulted in press release in some of the largest newspapers in Norway. The school was founded in 1951.
1992: Best overall score of all time when graduating from junior high school.

Awards/Honours Based on Co-Author Contribution (10)

Awards/Honours Based on Co-Author Contribution (10):
2018: 14th International Sjogren’s Syndrome Symposium Travel Award (co-author contribution)
2017: International Colour Vision Society Travel Award (co-author contribution)
2017: Best paper at the Department of Medical Biochemistry, Oslo University Hospital (August to December, 2017), resulting in nomination to the twice yearly best paper contest at Oslo University Hospital. A maximum of 25 papers twice a year can be nominated from the entire hospital (last author contribution)
2016: Best thesis (PMID: 28811665) at the Department of Oral biology, Faculty of Dentistry, from January 2014 to January 2016, resulting in the nomination for The Kings Gold Medal, University of Oslo, Norway. PhD candidate: Rakibul Islam; main supervisor Tor Paaske Utheim; title of thesis: Treatment of Limbal Stem Cell Deficiency: Cell-Based Regenerative Therapy and Storage System (main supervisor contribution)
2016: Best paper (PMID: 26940175) at the Department of Medical Biochemistry, Oslo University Hospital (January to July, 2016), resulting in nominated to the best paper contest at Oslo University Hospital. A maximum of 25 papers twice a year can be nominated from the entire hospital (last author contribution)
2015: EULAR Conference, Zürich, Switzerland: Poster Selected to “Guided Poster Tour”  (co-author contribution)
2014: ARVO International Travel Grant (last author contribution)
2012: Best Paper Award, Socleta Italiana Cellule Staminali e Superficie Oculare, Rome, Italy based on the paper: Chen X,  Stojanovic A, Stojanovic F, Raeder S, Eidet JR, Oritsland H, Utheim TP: Effect of limbal marking prior to laser ablation on the magnitude of cyclotorsional error. J Refract Surg. 2012 May;28(5) (last author contribution)
2010: ARVO International Travel Grant (co-author contribution)
2008: Director`s Award for Excellent Research, Oslo University Hospital (second-author contribution)

Publicity Based on Innovation/Research From My Research Group: (Television: 3, Newspaper: 4, Webpages: Numerous):

Television:
EuroNews, Science/Hi-Tec, week 38, 2007 (the main European news channel).
NRK Dagsrevyen, August 16, 2007 (the main Norwegian news channel)
Schrødingers Katt, September 2, 2010 (the main Norwegian science channel)
Newspapers (a selection):
Dagens næringsliv, August 11, 2017
Optikeren (nr 1. 2016)
Klassekampen (February 26, 2016)
Alt om syn (Norwegian journal about vision), October 28, 2011 and issue nr 4, 2015
Nationen (Norwegian newspaper), September 5, 2015
The Journal of the Norwegian Medical Association, August 12, 2010
Aftenposten (main Norwegian newspaper) November 22, 2007
Ullevål-Nytt (newspaper for Oslo University Hospital, Ullevål), December, 2007
Web Pages:
tidsskriftet.no, forskning.no (x3), forskningsradet.no (x2), EuroNews.com (main page), nrk.no, helse-sorost.no, oslo-universitetssykehus.no, tannlegeforeningen.no, medinnova.no, blindeforbundet.no, abcnyheter.no, optikeren.no, dn.no, innovationmanagement.se, sciencedaily.com, ntbinfo.no, medicaldaily.com, healthcanal.com, odont.uio.no, uio.no (main page for 10 days), MedicalXpress.com, scifeeds.com, scincenordic.com, dental-tribune.com, etc

Administrative Qualifications (19 Administrative Positions Since 2008):

2018- present              Professor, Oslo Metropolitan University, Oslo, Norway
2018- present President of the Oslo Society of Ophthalmology (established 1905), Oslo, Norway
2018–present Head, Unit for research-based innovation, Division of Head, Neck and Reconstructive Surgery, Oslo University Hospital, Oslo, Norway
2017- present Director of Innovation/Senior Consultant/Senior Scientist, Stavanger University Hospital, Stavanger, Norway
2017 - present Director of Research/Director of Innovation/Senior Consultant Department of Ophthalmology, Sørlandets Sykehus, Arendal, Norway
2016 –present  Editor-in-Chief for Oftalmolog, a Nordic Journal of Ophthalmology
2016 –present  Director of Innovation, Division of Head, Neck and Reconstructive Surgery, Oslo University Hospital, Norway
2015 –present  Director of Research, Department of Ophthalmology, Drammen Hospital, Norway
2015 –2017  Vice President, The Norwegian Society of Ophthalmology, Oslo, Norway
2015 - 2016 Director of Innovation, Oslo University Hospital, Norway
2013 - present Acting Group Leader and later (2014) Group Leader of the Unit of Regenerative Medicine, Department of Medical Biochemistry, Oslo University Hospital
2014 - present Head of the electron microscopy laboratory, Institute of Oral Biology, Faculty of Dentistry, University of Oslo (since autumn 2015 shared position with Professor Linda Hildegard Bergersen) 
2014 - present            Head of the Scientific Committee of Aniridia Europe
2011 - present            Head of the Scientific Committee of Aniridia Norway
2012 - 2013            Director of Research, the Dry Eye Clinic, Oslo and Tromsø, Norway
2012 - 2013 Chief Executive Officer of SynsLaser (private eye clinic with its own unit for research and development) in Oslo and Tromsø, Norway
2010 Chief Scientific Officer of Regena Medical AS, Norway
2009 Director of Research for Ophthalmology, Inven2, Oslo University Hospital
2008 Shared Project Leader (with Professor Darlene A. Dartt) on a project related to storage of cultured cells at Schepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, US

Funding:

Total funding based on grant applications as either project leader or project collaborator over the past 10 years has increased steadily and now amounts to approximately $22 million, about half of which was secured over the past 3 years. The funding includes an EU grant (Horizon 2020) of $5 million (consortium member) and a Norwegian Research Council grant of $1.3 million (principal investigator)

Teaching and Pedagogic Qualifications:

Co-authored a book with Sten Ræder, Utheim TP, and Utheim OA entitled: Ophthalmology – basal clinical examination (Unipub, Oslo, Norway, 2012, 133 pages), which has been distributed to thousands of medical students in Norway and abroad since 2008. The authors are in the final stages of writing a more comprehensive book on ophthalmology
Teaching responsibilities in ophthalmology to more than 650 medical students since 2004. None of them failed their oral examination

Establishment of Companies:

2017 - Velotrail (bike safety company)
2016 - The Eye Health Clinic
2016 - The Glaucoma Clinic
2015 - Digital Ophthalmology
2012 – The Norwegian Dry Eye Clinic
2010 - Regena Medical (a biotech company)

International collaboration:

Number of scientists in my group previously or currently performing research at Department of Ophthalmology, Harvard Medical School: 38

Invited Talks (in Total: 101, Whereof 34 International (Underlined)):

MSD Ophthalmology National Meeting, Oslo, Norway, 2006
XXXVII Nordic Congress of Ophthalmology, Copenhagen, Denmark, 2006
The Norwegian Society of Ophthalmology, Oslo, Norway, 2006
Pfizer`s Supplementary Training Meeting, Oslo, Norway, 2007
Oslo University Innovation talk at the “Opening of the Idea Polyclinic, Ullevål” with press coverage, August 17, 2007
Invited Speaker, Oslo Ophthalmology Society, Oslo, Norway, 2007
Oslo and Akershus University College, Norway, 2007
Inven2 Innovation prize talk, Rikshospitalet, Oslo University Hospital Norway (the main auditorium with press coverage), November 21, 2008
Cornea Innovation, Soria Moria, Oslo, Norway, September 2, 2008
Cambridge Innovation Center, Cambridge, MA, October 16, 2008
Inven2 Innovation prize talk with status after one year, Rikshospitalet, Oslo University Hospital Norway, November 20, 2009
Kyoto Prefectural University of Medicine, Japan, December 2009
El Centro de Oftalmologia Barraquer, Barcelona, Spain, August, 2009
Transplant Services Foundation, Hospital Clínic i Provincial de Barcelona, Spain, August, 2009
Invited Speaker, BMI (Biomedical innovation AS), Oslo, Norway, August 25, 2009
Invited Speaker, NeoMed, Oslo, November, Norway, 2009
DnB Nor, Oslo, Norway, November 2009
DLA Piper, Oslo, Norway, November 2009
Invited Speaker, Sigma fondsforvaltning AS, Oslo, Norway, September 10, 2009
Oslo University Hospital, Ulleval, Oslo, Norway, October 17, 2009
Southern and Eastern Norway Regional Health Authority Board Meeting (talk on innovation), Drammen, Norway December 10, 2009
The Norwegian Stem Cell Meeting, Losby, Lørenskog, Norway, October 19, 2010
The 2nd Asia Cornea Society Biennial Scientific Meeting, Kyoto, Japan, December 2, 2010
SOE Lecturer, The Norwegian Society of Ophthalmologists, Soria Moria, Norway, November 2, 2012
Harvard Cornea Center of Excellence Scientific Retreat, The American Academy of Arts and Sciences, US, December 15, 2012
Thea Laboratories (invited talk for the administration) Seattle, Washington, US, May 6, 2014
Schepens Eye Research Institute, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, US, May 30, 2013
Wayne State University, Detroit, US, June 24, 2013
The Royal Society of Medicine, London, UK, October 19, 2013
Department of Plastic and Reconstructive Surgery, Oslo University Hospital, Oslo, Norway, February 28, 2014
Newcastle University, Newcastle, UK, June 3, 2014
The German Ophthalmological Society, Leipzig, September 27, Germany, 2014
2nd European Conference on Aniridia, September 19, Italy, 2014
COST Training School, Nottingham, September, UK, 2014
Kongsberg Vision Meeting, October 27, 2014
Oslo Vest Rotery Club, October 29, 2014
BI Norwegian Business School, Oslo, Norway, September 3, 2014
University of California, Berkeley (BI Innovation project), CA, US, October 17, 2014
Craniofacial development biology course, Department of Oral Biology, University of Oslo, March 16, 2015
Aniridia Norway, Hurdal, Akershus, Oslo, May 30 2015
Oslo University Hospital Research Seminar (October 19, 2015)
Sundvolden Conference Center, Hønefoss, Norway (October 27, 2015)
Oslo Conference Center, Oslo, Norway (November 12, 2015)
Oslo University Hospital Seminar (December 7, 2015)
Innovation at Oslo University Hospital: “Brukerutvalget” Oslo University Hospital, March 25, 2016
The rationale for establishing a joint test bed for Oslo University Hospital and Oslo Municipality, Board of Directors, Oslo University Hospital, April 28, 2016
Testbeds in the health sector, Innovation network for the Southern Eastern Norway Regional Health Authority, Oslo, Norway, April 13
The rationale for establishing a joint test bed for Oslo University Hospital and Oslo Municipality, Conference for Health and Medical Technology, Drammen, April 14, 2016
Innovation – the sky is the limit, Telemark Hosptial Trust, Farris bad, Larvik, Norway, May 31, 2016
Innovation in dentistry, Faculty of Dentistry, Quality Hotel Leangkollen, Asker, Norway, June 1, 2016
Innovation – Oslo Tech, Oslo Science Park, Oslo, Norway, June 2, 2016
Innovation in ocular stem cell therapy, Department of Ophthalmology, Drammen Hospital, June 2, 2016
The use of oral mucosal cells for treating corneal blindness - how can it be possible and what other  options are there in 2016? The Harvard seminar, Faculty of Dentistry, University of Oslo, June 8, 2016
The rationale for the establishment of test beds for Oslo University Hospital and Oslo Municipality, Oslo University Hospital, Aker, June 15, 2016
Nordic Congress of Ophthalmology, Aarhus, Denmark 8-12 June
Innovation strategy for medical students, University of Oslo, August 15, 2016
The rationale for a testbed for Oslo University Hospital and the Municipality of Oslo, European telemedicine conference, Oslo Spectrum, Norway, August 16, 2016
Innovation in the health sector from an economic perspective, Oslo University Hospital (two-days seminar for economics at the hospital), August 25, 2016
3rd Scientific European Aniridia Conference 27-28th August 2016, Duisburg, Germany
Innovation seminar, Faculty of Dentistry, University of Oslo (both speaker and moderator), January 18, 2017
Limbal stem cell deficiency, Charles University, Prague, Czech Republic, January 19, 2017
Innovation in the future, Division of Head, Neck and Reconstructive Surgery, Oslo University Hospital (two-days seminar, Norefjell, Norway, March 3, 2017
Stem cells and innovation – What is possible in 2017? - Agder Eye Seminar [Agder Øyelegeforum], Lillesand, Norway, March 7, 2017
Craniofacial development biology course, Department of Oral Biology, University of Oslo, March 20, 2017
Stem cell therapy, National Centre for Optics, Vision and Eye Care, University College of Southeast Norway, Norway, March 31, 2017
Treatment of corneal blindness - Norwegian Institute for air research, Kjeller, Norway, April 6, 2017
Innovation – opportunities and pitfalls, National Centre for Optics, Vision and Eye Care, University College of Southeast Norway, Norway, June 2, 2017
Innovation, Novartis Nordic Meeting, Tallinn, August 23, 2017
Dry eye disease – an update, Novartis Nordic Meeting, Tallinn, August 23, 2017
Stem cell in ophthalmology, Novartis Nordic Meeting, Tallinn, August 23, 2017
Dry eye disease – upcoming treatment strategies, Novartis Nordic Meeting, Tallinn, August 24, 2017
Innovation at Oslo University Hospital, Monrad Krohn Auditorium, Oslo, Norway, October 11, 2017
Innovation at the Univeristy of Oslo, Faculty of Dentistry, Oslo, Norway, November 1, 2017
Opportunities in Innovation, Oslo University Hospital, Monrad Krohn Auditorium, November 3, 2017
Ophthalmology for general practitioners, Novartis, Grand Hotel, Oslo, Norway, November 17, 2017
Innovation in research, OsloMet (three-hours seminar for research leaders at the university), Pilestredet 46, 0167 Oslo, Norway, January 24, 2018
Innovation, OsloMet (invited talk at a one-day seminar for the entire administration, including Rector, at OsloMet), Bristol hotel, Kristian IVs gate 7, 0164 Oslo, Norway, January 31, 2018
Innovation, Stavanger University Hospital, February 6, 2018
Innovation - what, why and how, Clinic of Neurology, Oslo University Hospital, February 28, 2018
Innovation, OsloMetropolitan University, March 7, 2018
Experiences from the Norwegian Dry Eye Clinic, Norvartis Nordic Advisory Board, Stockholm, March 21, 2018
Dry Eye Disease/The Norwegian Dry Eye Clinic, Novartis Ophthlamic Days, Nyborg, Denmark, April 14, 2018,
Research driven innovation, Kosmopol, Copenhagen, Denmark, April 15, 2018
Innovation and ophthalmology, Boston University, April 26, 2018
Future innovation at Stavanger University Hospital, Stavanger University Hospital (invited by the CEO of the hospital), May 22, 2018
Management of dry eye disease, Shire, Stockholm, May 30, 2018
Innovation inspirational seminar (IT - students about 200 participants), Oslo Metropolitan University, Oslo, August 14, 2018
Dry eye disease – an update, Thea Laboratoies and Iogen, Helsinki, Finland, August 17, 2018
Innovation - why, when, how, Thea Laboratoies and Iogen, Stockholm, Sweden, August 18, 2018
Dry eye disease - unmet needs, Elsemay Björn symposium, Tampere, Finland, August 20
Stem cells: possibilities for therapy in 2018 – Nordic Congress of Ophthalmology, Oslo, August 22, 2018
Is it possible to do research in private practise? – Nordic Congress of Ophthalmology, Oslo, August 24, 2018

Innovation inspirational seminar, Oslo Metropolitan University (students with various background - about 300 participants), Oslo, August 27, 2018

Innovation – what, why and how; Resarch group leadership seminar, Division of Laboratory Medicine and Division of Radiology and Nuclear Medicine, Oslo, September 19, 2018

Swedish Ophthalmology Society, Thea Symposium on dry eye disease, Stockholm, Sweden, October 8, 2018

Swedish Ophthalmology Society, Santen Symposium on dry eye disease, Stockholm, Sweden, October 9, 2018 (moderator with brief, introductory talk on dry eye disease)

Dry Eye Disease, University Hospital of North Norway (ophthalmology residents, 70 participants), Oslo, October 23, 2018

Innovation inspirational seminar, Oslo Metropolitan University (physiotherapists and nurses - about 120 participants), Oslo, October 26, 2018

Innovation Seminar, Division for Head, Neck and Reconstructive Surgery, presenter, moderator and organizer, Oslo, November 6, 2018

Ophthalmology for general practitioners, Novartis, Radison SAS, Holberg plass, Oslo, Norway, November 1, 2017

Innovation – Myths and Facts, Monrad Krohn Auditorium, Oslo, Norway, November 6, 2017

Innovation and artificial intelligence; Symposium on Artificial Intelligence, AIM 2 North 2018 - Explore the possibilities and impact around Artificial Intelligence, connecting Man and Machine; Main Auditorium, Oslo Metropolitan University, Oslo, November 7, 2018

Other (in Chronological Order):

1998: Co-founder of “I Ragazzi”. This unit was responsible for writing MED NYTT, a booklet for medical students that was published monthly for many years, and organizing classical music concerts and film events at regular intervals for medical students at the Faculty of Medicine in Oslo, Norway
Disclosure of Invention (6 submitted since 2006; all accepted by Inven2, the largest Technology Transfer Office in Norway)
2007: The first stem cell transplantation in Scandinavia using ex vivo cultured limbal epithelial cells was performed at the Department of Ophthalmology, Oslo University Hospital. To my knowledge, this transplantation was the first worldwide to include storage of cultured limbal epithelial cells for 4 days prior to the operation. The transplantation was based on research that resulted in a double PhD thesis on eye bank storage of cultured cells for Sten Ræder and me
2010: Co-founder of a biotech company based on my own inventions in collaboration with Medinnova AS, which is now named Inven2
2010–present: Reviewer for scientific journals, including Progress in Retinal and Eye Research (impact factor: 11.5 ×1), Nanomedicine (5-year impact factor: 7 ×5), Stem Cells (impact factor: 6 ×1), Scientific Reports (impact factor: 5.5 × 2), Stem Cell Research & Therapy (×1), PLOS ONE (×1), Ocular Surface (×1), IOVS (×2), Experimental Eye Research (×1), Acta Ophthalmologica (×2), Current Eye Research (×2), Journal of Materials Science (×2), Organogenesis (×1), and Scandinavian Journal of Optometry and Visual Science (×1)
2011–present: Associate member of the National Center for Stem Cell Research in Norway
2011–present: Classical music advisor for The Center for Studies of Holocaust and Religious Minorities, University of Oslo, Oslo, Norway
2012: Co-founder of the first Dry Eye Clinic in Scandinavia. The research clinic has recently expanded nationally and internationally (Iceland) and received substantial funding for research from several sources, including the Norwegian Research Council, The Association for the Blind and Partially Sighted in Norway, a public hospital (Elverum, Norway), 8 pharmaceutical companies, and a private eye clinic in Iceland
2011–present: Editorial board member for Medark, University of Oslo
2012–present: Editorial board member for Oftalmolog, a Nordic journal of ophthalmology
2012: Development of a software (A Dry Eye Management System, ADEMS) in collaboration with Sten Ræder to enable improved diagnostics of dry eye disease and analysis of data for quality assessment or research. The software has resulted in great interest from eye clinics both in Norway and abroad as well as from the pharmaceutical industry, resulting in substantial external funding to further develop the software
2013–present: Member of the Scientific Committee of Aniridia Europe
2013–present: External examiner for 4 master’s theses
2013–present: Regular columnist for the Norwegian journal Alt om Syn (“Everything About Vision”). Circulation: up to 700,000, 4 times yearly
2014–present: Member of Network of Excellence in Corneal Regeneration, an EU research network based on EU funding (European Cooperation in Science and Technology [COST] Actions)
May 4, 2014: Moderator at ARVO (the world’s largest eye congress)
September 19, 2014: Expert panel member at the 2nd European Conference on Anirida, Italy
2014–present: Evaluator of 2 master’s thesis and one digital publication following a 3-month medical research program at the University of Oslo
Effective August 2014: Appointed “Innovation Contact” for several departments at Oslo University Hospital by the Oslo University Hospital Director of Innovation. My main task is to explore the innovative potential of research in these departments
2014: Invited author of several review articles in several journals, including Journal of Functional Biomaterials (×3), Ophthalmology and Therapy (×1), and Medical Hypothesis, Discovery & Innovation Ophthalmology Journal (×1) (several manuscripts are currently in preparation)
Author of several popular scientific reports and commentaries, including “Iris,” “Technical Weekly Magazine,” “Everything about Vision” (several times), and in the Journal of the Norwegian Medical Association
December 2014: Board Member of NORBRAIN (Norwegian Brain Initiative; 14 members, including Nobel Prize Laureate Edvard Moser)
Effective 2014: Funding without time restrictions for 4 full-time scientific positions at Oslo University Hospital
June 2014: Appointed Head of the Electron Microscopy Laboratory, Institute of Oral Biology, University of Oslo. The laboratory has 2.5 technicians. Since the last quarter of 2015, I have shared the position with Professor Linda Hildegard Bergersen
Submitted January 2015: Partner in EU application related to Innovation
January 9, 2015: Best grade “A” at the oral exam for the first-third of a master’s degree in management in collaboration with The Norwegian Business School; University of California, Berkeley; and Stanford University
January 27, 2015: Interview on stem cells by Nature Biotechnology on regenerative medicine [Nature Biotechnology, 33 (3), March 2015]
March 5, 2015: Best grade “A” for thesis for the first-third of a master’s degree in management in collaboration with The Norwegian Business School; University of California, Berkeley; and Stanford University. The head of the innovation program at The Norwegian Business School has included our thesis in the teaching material as an example of an outstanding thesis to inspire new classes
March 6, 2015: Accepted for the Research Leadership Programme at the University of Oslo for 2015
March 6, 2015: Head of a Strategy Committee on the role of innovation contacts at Oslo University Hospital (appointed by the Oslo University Hospital Director of Innovation)
April 20, 2015–present: Editorial board member of International Journal of Experimental Dental Science
April 11, 2015: Invited as co-organizer of the Corneal Regenerative Medicine session at the Nordic Congress of Ophthalmology in Denmark in 2016, which included an invitation to appoint a keynote speaker
May 2015: Invited to be Moderator at ARVO
June 17, 2015: Assessed as Professor Competent at the Faculty of Medicine, University of Oslo, at the first attempt of such evaluation (CV submitted January 17, 2015, at the age of 38 years). The assessment report concludes: “He is an ideal clinician-scientist with large potential to make major contributions in translational medical research.”
June 19, 2015: External examiner of one PhD thesis
July 20, 2015: Invited by the organizers of the 2016 Nordic Congress of Ophthalmology in Denmark to give a talk entitled “How to fast track your research career?” based on recent academic progress
August 28, 2015: Appointed as assessment committee member to select the best publication during the first 6 months of 2016 from the Division of Diagnostics and Intervention, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo
October 19, 2015: Co-organizer and co-chair for the Oslo University Research Seminar
December 7, 2015: Member of the 3rd Aniridia Europe Conference Scientific Organizer Committee
October 2015: Appointed member of the advisory/working group of the Director of Innovation of the Southern Eastern Norway Regional Health Authority
October 2015: Appointed project leader for the test lab project in collaboration with Oslo University Hospital and the municipality of Oslo
2016: The only employee of the University of Oslo Faculty of Dentistry nominated for the University of Oslo Innovation Prize
2016: Abstract nominated by the organization committee of the European Society of Ophthalmology for best poster award (co-author contribution)
May 2016: Invitation to serve as moderator for 3 corneal sessions (paper: 267 - Corneal Epithelium Health and Disease, poster: 144 - Corneal Regenerative Medicine, poster: 439 - Corneal refractive surgery II) at ARVO, Seattle, TX
2016: Invited to serve as Lead Guest Editor for a Special Issue of Journal of Ophthalmology
2016: Appointed member of the Innovation Advisory Board, Oslo University Hospital
June 8, 2016: Moderator of 2016 Oslo Dental Science Forum, Oslo Congress Center, Oslo, Norway
August 25, 2016: Appointed “Innovation Contact” (i.e., responsible for innovation) for the Clinic of Laboratory Medicine, Oslo University Hospital. The Clinic of Laboratory Medicine is the largest clinic at the Institute of Clinical Medicine, Oslo University Hospital
2016 - 2017: Examination committee member, Faculty of Dentistry, University of Oslo (the work consists of planning, writing, and correction of exams)
January 1, 2017: Appointed Editor-in-Chief for Oftalmolog
February 24, 2017: Appointed Norway Ambassador for the Tear Film & Ocular Surface Society. Only one ambassador is appointed from each country
March 25, 2017: Reviewer for Biotechnology and Biological Sciences Research Council (BBSRC), the lead funding agency for academic research and training in the biosciences at universities and institutes throughout the UK
May 4, 2017: Granted EU funding: Horizon 2020—Research and Innovation Framework Programme. Project title: Functional Hybrid Coatings by Molecular Layer Deposition (consortium member)
May 6, 2017: Member of the Novartis Global Ocular Surface Advisory Board
May 2017: Appointed member of the organizing committee and scientific committee for the Nordic Congress of Ophthalmology 2018 in Oslo, Norway
May 2017: Invitation to serve as moderator for the dry eye disease and the corneal regenerative medicine paper session at the Nordic Congress of Ophthalmology 2018 in Oslo, Norway
May 7-11, 2017: Moderator for 2 scientific sessions (dry eye disease and corneal biomechanics) at ARVO, Baltimore, US
June 2017, Co-founder of Velotrail AS (company devoted to innovations related to bike security—6 co-founders, including previous Oslo University Hospital Director of Innovation, Kari Kværner)
September 2017 to February 2018: Leadership development program, Oslo University Hospital
2017: Head of PhD Committee for Miriam Landfors’s PhD thesis entitled: “Regulatory nucleotide modifications in Sertoli cells and germ cells.” First opponent: Dr. Gabriella Ficz, Centre for Haemato-Oncology, Barts Cancer Institute, John Vane Science Centre, Charterhouse Square, London, UK. Second opponent: Ann-Karin Olsen; Department of Molecular Biology
Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
April, 2018: Appointed professor in innovation at Oslo Metropolitan University, Oslo, 2018 (the first and currently only professorship in innovation at Oslo Metropolitan University)
April 30, 2018: Moderator for a paper session (Dry Eye Clinical) at ARVO, Honolulu, Hawaii
May 2, 2018: Moderator for a poster session at ARVO (Dry Eye Clinical II), Honolulu, Hawaii
August 9, 2018: Member of the evaluation committee for the Innovation Competition at Oslo Metropoltian University Hospital, resulting in the Oslo Metropoltian University Award of NOK 80,000. The other members were Kristin Sverdrup, Director of Research, Oslo Metropoltian University Hospital and Christian Bjerke, Director of Innovation for Simula Innovation (https://www.simula.no)
August, 2018: Consultant, Mundipharma AS, Dicks vei 10B, 1366 Lysaker, Norway

Patent Applications Submitted (6)

United Kingdom Patent Application No. WO/2008/131973: Transplant storage I. Submitted by Inven2 April 26, 2007
United Kingdom Patent Application No. WO/2008/131973: Transplant storage II. Submitted by Inven2 April 4, 2008.
United Kingdom Patent Application No. 1020436.0: Instant transplatation of cells Submitted by Stavanger University Hospital. Submitted by Inven2 December 2, 2010.
United Kingdom Patent Application. A novel storage method for cultured retinal pigment epithelial cells for transplantation. Submitted by Inven2 Februar 28, 2014.
United Kingdom Patent Application. A novel storage method for mammalian cells, tissue and organs. Submitted by Inven2 Februar 28, 2014.
United Kingdom Patent Application No. 1511482.0: Growth medium retinal pigment epithelial (RPE)-cells. Submitted by Inven2 Juni 30, 2015.

References:

Torstein Lyberg, MD, PhD, previous Director of Research at Unit of Regenerative Medicine, Department of Medical Biochemistry, Oslo University Hospital and main supervisor for my PhD; e-mail UXTOLY@ous-hf.no
Numerous other references and letters of recommendation (in total 23) can be given on request from all previous employers.
Emneord: regenerative medicine, stem cells, oral mucosa

Publikasjoner

Publications or Submitted Manuscripts in Peer-Reviewed Journals:

1. Ritland S, Utheim TP, Utheim OA Espeseth T, Lydersen S, Semb SO, Rootwelt H, Elsås T: Effects of APOE and CHRNA4 genotypes on retinal nerve fibre layer thickness at the optic disc and on risk for developing exfoliation syndrome. Acta Ophthalmol Scand. 2007 May; 85(3): 257-61
2. Utheim TP, Raeder S, Utheim OA, Cai Y, Roald B, Drolsum L, Lyberg T, Nicolaissen B: A novel method for preserving cultured limbal epithelial cells, Br J Ophthalmol. 2007 Jun; 91(6): 797-800
3. Raeder S, Utheim TP, Utheim OA, Cai Y, Roald B, Lyberg T, Kjeldsen-Kragh J, Ramstad H, Messelt E, Nicolaissen B: Effect of limbal explant orientation on the histology, phenotype, ultrastructure and barrier function of cultured limbal epithelial cells. Acta Ophthalmol Scand. 2007 Jun; 85(4): 377-86 (Cover page)
4. Raeder S, Utheim TP, Utheim OA Nicolaissen B, Roald B, Cai Y, Haug K, Kvalheim A, Messelt EB, Drolsum L, Reed JC, Lyberg T: The Effects of Organ Culture and Optisol-GS Storage on Structural Integrity, Phenotypes, and Apoptosis in Cultured Corneal Epithelium, Invest Ophthalmol Vis Sci. 2007 Des; 48(12): 5484-5493
5. Utheim OA, Ritland JS, Utheim TP Espeseth T, Lydersen S, Rootwelt H, Semb SO, Elsås T: Apolipoprotein E-genotype and risk of development of cataract and age-related macular degeneration. Acta Ophthalmol Scand. 2008 Jun;86(4):401-3
6. Utheim TP, Raeder S, Utheim OA de la Paz M, Roald B, Lyberg T: Sterility control and long-term eye-bank storage of cultured human limbal epithelial cells for transplantation. Br J Ophthalmol. 2009 Jul;93(7):980-3
7. Utheim TP, Raeder S, Olstad OK Utheim ØA, de La Paz M, Cheng R, Huynh TT, Messelt E, Roald B, Lyberg T: Comparison of histology, gene expression, and phenotype of cultured limbal epithelial cells of different limbal regional origin. Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5165-72.
8. Raeder S, Utheim TP, Messelt E, Lyberg T: The impact of de-epithelialization of the amniotic membrane matrix on morphology of cultured human limbal epithelial cells subject to eye bank storage" Cornea. 2010, Apr;29(4):439-45.
9. Chen X. Stojanovic A, Zhou W, Utheim TP, Stojanovic F, Wang Q. Tansepithelial, topography-guided ablation in treatment of visually disturbing irregular astigmatism and/or scattering in Lasik-flap/interface complications. J Refract Surg. 2012 Feb;28(2):120-6 
10. Eidet JR, Utheim OA, Raeder S, Dartt DA, Lyberg T, Carreras E, Huynh TH, Messelt E, Louch WE, Roald B, Utheim TP. Effects of Serum-free Eye Banking on Morphology, Phenotype, and Viability of Ex Vivo Cultivated Human Conjunctival Epithelium
Exp Eye Res. 2012 Jan; 94(1):109-16
11. Eidet JR, Fostad I, Shatos M, Utheim TP, Utheim OU, Raeder S, Dartt DA. Effect of Biopsy Location and Size on Proliferative Capacity of Ex Vivo Expanded Conjunctival Tissue Invest Ophthalmol Vis Sci. May 14;53(6):2897-903
12. Stojanovic A, Chen X , Zheng L, Xu Y, Stojanovic F, Utheim TP.  Late onset post-LASIK keratectasia with reversal and stabilization after use of Latanoprost and corneal collagen cross-linking. Eye Report, 2012 doi:104081
13. Chen X, Stojanovic A, Stojanovic F, Raeder S, Eidet JR, Oritsland H, Utheim TP. The effect of limbal marking prior to laser ablation on the magnitude of cyclotorsional error. J Refract Surg. 2012 May;28(5):358-62.
14. Stojanovic A, Chen X, Nan J, Stojanovic F, Raeder S, Zhang T, Utheim TP: Safety and efficacy of epithelium-on corneal collagen cross-linking using a multifactorial approach to achieve proper stromal riboflavin saturation, J Ophthalmol, 2012; 2012:498435
15. Fostad I, Eidet JR, Shatos M, Utheim TP, Utheim OU, Raeder S, Dartt DA: Biopsy harvesting site and distance from the explant affect conjunctival epithelial phenotype ex vivo
Exp Eye Res. 2012 Nov; 104:15-25
16. Engelsvold D, Utheim TP, Olstad OK, Pedro Gonzalez, Eidet JR, Lyberg T, Trøseid AM, Dartt DA, Raeder S: miRNA and mRNA Expression Profiling Identifies Members of the miR-200 Family as Potential Regulators of Epithelial-Mesenchymal Transition in Pterygium. Exp Eye Res. 2013 Oct;115:189-98
17. Pasovic L, Utheim TP, Lyberg T, Messelt EM, Chen DF, Aabel A, Chen X, Eidet JR: Optimization of Storage Temperature for Cultured ARPE-19 Cells.  J Ophthalmol. 2013;2013:216359. Epub 2013 Oct 22
18. Stojanovic A, Chen S, Chen X, Stojanovic F, Zhang J, Zheng L, Utheim TP: One-step transepithelial topography-guided ablation in the treatment of myopic astigmatism PLOS ONE. 2013 Jun 17;8(6)
19. Lagali N, Edén U, Utheim TP, Dellby, A, Riise R, Chen X, Fagerholm P:  In vivo morphology of the limbal Palisades of Vogt correlates with progressive stem cell deficiency in aniridia-related keratopathy. Invest Ophthalmol Vis Sci 2013 Aug 7;54(8):5333-42
20. Liu Y; Yang X; Utheim TP; Guo C; Xiao M; Liu M; Ma: Correlation of Cytokine Levels and Microglial Cell Infiltration during Retinal Degeneration in RCS Rats, PLoS One. 2013 Dec 13;8(12):e82061
21. Utheim TP. Limbal epithelial cell therapy: past, present, and future, Methods Mol Biol. 2013;1014:3-43 (single author - 40 pages)
22. Parissi M, Karanis G, Randjelovic S, Germundsson J, Poletti E, Ruggeri A, Utheim TP, and Lagali N. Establishing a Standardized Baseline Human Corneal Subbasal Nerve Density for Clinical Investigations with Laser-scanning in Vivo Confocal Microscopy Invest Ophthalmol Vis Sci. 2013 Oct 29;54(10):7091-102
23. Utheim TP (2014). Why test BCG in Sjögren`s syndrome? In Faustman, D. (Ed.) “The Value of BCG and TNF in Autoimmunity”, London, Elsevier, pp. 105-125. (single author – 20 pages)
24. Islam R, Jackon C, Eidet JR, Messelt EB, Corraya RM, Lyberg T, Griffith M, Dartt DA, Utheim TP: Effect of Storage Temperature on Structure and Function of Cultured Human Oral Keratinocytes. PLoS One. 2015 Jun 8;10(6)
25. Utheim TP, Lyberg T, Raeder S. (2013) Culture of Limbal Epithelial Cells In Connon C. and Wright B. (Eds.). Methods Mol Biol. pp. 103-29 (27 pages)
26. Eidet JR, Pasovic L, Corroya RM, Jackson C, Utheim TP: Objective Assessment of Changes in Cell Nucleus Morphology and Cell Distribution Following Induction of Apoptosis Diagn Pathol. 2014 May 12;9:92.
27. Pasovic L, Eidet JR, Lyberg T, Messelt EM, Aabel A, Utheim TP: Antioxidative Substances Improve the Viability of Stored ARPE-19 Cultures, Ophthalmol Ther. 2014 Mar 29.
28. Utheim TP, Hodges R.R. and Dartt D.A. (2014) The Eyelid. In: Linda M. McManus, Richard N. Mitchell, editors. Pathobiology of Human Disease. San Diego: Elsevier; 2014. Pp 2201-2215
29. Edén U, Lagali N, Dellby, A, Utheim TP, Riise R, Chen X, Fagerholm P: 
Cataract development in Norwegian patients with congenital aniridia. Acta Ophthalmol. 2014 Mar;92(2)
30. Stojanovic A, Zhou W, Utheim TP: Corneal Collagen Cross-Linking with and without Epithelial Removal – Contralateral Study with 0.5% Hypotonic Riboflavin Solution. Biomed Res Int. 2014;2014:619398. Epub 2014 Jun 22
31. Chen X, Stojanovic A, Hua Y, Eidet JR, Hu D, Wang J, Utheim TP: Repeatability and Reproducibility of Corneal Dynamic Scheimpflug Analyzer in Virgin and Post-PRK, PLoS One. 2014 Oct 10;9(10):e109577
32.  Jackson C, Aabel P, Eidet J, Messelt E, Lyberg T, von Unge M, Utheim TP: Xenobiotic Free Storage of Cultured Epidermal Cell Sheets for 14 Days – Effects of Temperature on Viability, Morphology, and Metabolic Status, PLoS One. 2014 Aug 29;9(8):e105808
33. Eidet JR, Utheim OA, Islam R, Lyberg T, Messelt E, Dartt DA, Utheim TP: The Impact of Storage Temperature on the Morphology, Viability, Cell Number and Metabolism of Cultured Human Conjunctival Epithelium Curr Eye Res. 2015 Jan;40(1):30-9.
34. Bjoerkblom B, Eidet JR, Utheim TP, Ulltveit-Moe H, Raeder S: Xenobiotic- and Serum-Free Culture of Oral Mucosal Epithelial Cells on Contact Lenses for Ocular Surface Reconstruction Curr Eye Res. 2015 Aug 19:1-8.
35. Utheim TP: Transplantation of Cultured Oral Mucosal Epithelial Cells for Treating Limbal Stem Cell Deficiency - Current Status and Future Perspectives, Stem Cells. 2015 Jun;33(6):1685-95.
36. Utheim OA, Islam R, Lyberg T, Roald B, Eidet JR, De la Paz MF, Dartt DA, Raeder S, Utheim TP: Serum-Free and Xenobiotic-Free Preservation of Cultured Human Limbal Epithelial Cells PLoS One. 2015 Mar 3;10(3):e0118517.
37. Eidet, Jon Roger; Dartt, Darlene A.; Utheim, Tor P. Concise Review: Comparison of Culture Membranes Used for Tissue Engineered Conjunctival Epithelial Equivalents. Journal of Functional Biomaterials 2015, J Funct Biomater. 2015 Dec 11;6(4):1064-84
38. Hua Y, Stojanovic A, Utheim TP, Chen X, Ræder S, Huang J, Wang Q. Keratometric index obtained by Fourier-domain optical coherence tomography.PLoS One. 2015 Apr 17;10(4)
40. Salvanos P, Utheim TP, Moe MC, Bragadottir R, Eide N: Autofluorescence Pattern of Optic Disc Melanocytoma Acta Ophthalmol. 2015 Aug;93(5):476-80
41. Navaratnam J, Utheim TP, Shahdadfar A: Progress in Isolation and Culture Techniques in Tissue Engineering of Corneal Endothelium, J Funct Biomater. 2015 Sep 11;6(3):917-45.
42. Sehic A, Utheim ØA, Ommundsen K, Utheim TP. Pre-Clinical Cell-Based Therapy for Limbal Stem Cell Deficiency. J Funct Biomater. 2015 Aug 28;6(3):863-88.
43. Parissi M, Randjelovic S, Ruggeri A, Poletti E, Wihlmark TB, Utheim TP, and Lagali N.
Corneal Nerve Regeneration After Collagen Cross-Linking Treatment of Keratoconus: A 5-Year Longitudinal Study. JAMA Ophthalmol. 2015 Nov 12:1-9
44. Utheim TP: Future Avenues of Research in Aniridia In Poli/Parekh/Ferrari/Teofili/Ponzin (Eds) "Recent Developments in Scientific and Clinical Research”, Springer, 2015
45. Chen, X, Stojanovic A, Hu D, Zhou Y, Wang J, Utheim TP: Postoperative Changes in Corneal Epithelial and Stromal Thickness Profiles after Photorefractive Keratectomy in Treatment of Myopia, J Refract Surg. 2015 Jul;31(7):446-53
46. Pasovic L, Eidet JR, Brusletto BS, Lyberg T, Utheim TP: Effect of Storage Temperature on Key Functions of Cultured Retinal Pigment Epithelial Cells, J Ophthalmol. 2015;2015:263756.
47. Chen X, Stojanovic A, Eidet JR, Utheim TP: Treatment of keratoconus in thin corneas Eye and Vision 2015, Sept 2:15, 7
48. Lagali N, Enea P, Dipika PV, McGhee C, Hamrah P, Kheirkhah A, Tavakoli M, Petropoulos I, Malik R, Utheim TP, Zhyvov A, Stachs O, Falke K, Peschel S, Guthoff R, Chao C, Golebiowski B, Stapleton F, Ruggeri A: Agreement in the expert clinical assessment of corneal subbasal nerve tortuosity. Invest Ophthalmol Vis Sci. 2015 Aug 1;56(9):5102-9
49 Jackson C, Eidet JR, Reppe S, Aass HC, Tønseth KA, Roald B, Lyberg T, Utheim TP:
Effect of Storage Temperature on the Phenotype of Cultured Epidermal Cells Stored in Xenobiotic-Free Medium. Curr Eye Res. 2016 Jun;41(6):757-68
50. Sehic A, Khuu C, Utheim TP, Khan Q: MicroRNAs and Tooth Development;
Model for Organogenesis? Microrna. 2016;5(2):132-139.
51. Fostad I, Utheim TP, Eidet JR, Raeder S, Lagali N, Messelt E, Dartt DA: Dry Eye Disease Patients with Xerostomia Report Higher Symptom Load and Have Poorer Meibum Expressibility, PLoS One. 2016 May 5;11(5):e0155214.
52. Shatos MA, Hodges RR, Morinaga M, McNay DE, Islam R, Bhattacharya S, Turpie B,  Makarenkova HP, Masli S, Uthiem TP, Dartt DD: Alteration in Cellular Turnover and Progenitor Cell Population in Lacrimal Glands from Thrombospondin-1-/- Mice, a Model of Dry Eye, Exp Eye Res. 2016 Dec;153:27-41.
53. Salvanos P, Moe MC, Utheim TP, Bragadottir R, Kerty E: Ultra-Widefield Fundus Imaging in the Diagnosis and Follow-up of Susac’s Syndrome, Retin Cases Brief Rep. 2016 Nov 8.
54. Eidet JR, Reppe S, Pasovic L, Olstad OK, Lyberg T, Khan AZ, Fostad IG, Chen DF and Utheim TP: Silk-protein Sericin Induces Rapid Melanization of Cultured Human Retinal Pigment Epithelial Cells by Activating the NF-κB Pathway, Sci Rep. 2016 Mar 4;6:22671
55. Khan A, Utheim TP, Jackson C, Reppe S, Lyberg T and Eidet JR: 
Nucleus Morphometry in Cultured Epithelial Cells Correlates with Phenotype, Microsc Microanal. 2016 Jun;22(3):612-20. Neurochem Res. 2016 Jun;41(6):1229-36.
56. Kolko M, Vosborg F, Henriksen UL, Hasan-Olive M, Holm Diget E, Vohra R, Gurubaran G, Gjedde A, Mariga SH, Skytt D, Utheim TP, Storm-Mathisen J, Bergersen LH: Lactate Transport and Receptor Actions in Retina: Potential Roles in Inner Retinal Function and Disease, Neurochem Res. 2016 Jun;41(6):1229-36.
57. Fostad IG, Eidet JR, Lagali NS, Dartt DA, Raeder S, Messelt EB, Utheim TP
Identification of Objective Morphometric Markers of Xerostomia in the Oral Mucosal Epithelium With In Vivo Confocal Microscopy PLoS One. 2016 May 5;11(5):e0155214.
58. Sehic A, Khan Q, Utheim OA, Utheim TP: The Role of Substrates for Cultured Oral Mucosal Cells in Treating Limbal Stem Cell Deficiency J Funct Biomater. 2016 Mar 1;7(1).
59. Chen X, Stojanovic A, Wang X, Jing L, Hu D, Utheim TP: Epithelial Thickness Profile Change after Combined Topography-guided Transepithelial Photorefractive Keratectomy and Corneal Crosslinking in Treatment of Keratoconus, J Refract Surg. 2016 Aug 1;32(9):626-34.
60. Chen X, Stojanovic A, Simonsen D, Wang X, Liang J, Hu D and Utheim TP: Corneal Epithelial Thickness Profile Change After Corneal Collagen Cross-linking with and without Epithelial Removal in Treatment of Keratoconus, J Refract Surg. 2016 Jun 1;32(6):418-25
61. Assessment Zhou W, Stojanovic A, Utheim TP Assessment of refractive astigmatism and simulated therapeutic refractive surgery strategies in coma-like-aberrations-dominant corneal optics. Eye Vis (Lond). 2016 May 12;3:13
62. Utheim TP, Salvanos P, Utheim OA, Ræder S, Pasovic L, Olstad OK, Fideliz de la Paz M, Sehic A: Transcriptome Analysis of Cultured Limbal Epithelial Cells on Intact Amniotic Membrane Following Hypothermic Storage in Optisol-GS, J Funct Biomater. 2016 Feb 18;7(1)
63. Khuu C, Utheim TP, Sehic A: The Three Paralogous MicroRNA Clusters in Development and Disease - miR-17-92, miR-106a-363, and miR-106b-25; Scientifica (Cairo). 2016;2016:1379643
64. Utheim TP, Islam R, Fostad I, Eidet JR, Olstad OK, Sehic A, Messelt E, Dartt DA, Griffith M, Pasovic L, Eidet JR: Gene expression of cultured oral mucosal cells following xenobiotic-free storage for one week at 5ºC, 12ºC, and 37ºC, PLoS One. 2016 Mar 29;11(3)
65. He M, Storr-Paulsen T, Wang AL, Ghezzi CE, Wang S, Fullana M, Karamichos D, Utheim TP, Islam R, Griffith M, Islam MM, Hodges RR, Wnek GE, Kaplan DL, Dartt DA. Artificial Polymeric Scaffolds as Extracellular Matrix Substitutes for Autologous Conjunctival ex vivo Goblet Cell Expansion Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6134-6146.
66. Hua Y, Zhang X, Utheim TP; Huang J; Pan C; Tan W; Wang Q: Evaluation of Equivalent Keratometry Readings obtained by Pentacam HR (high resolution), PLoS One. 2016 Mar 7;11(3):e0150121. doi: 10.1371
67. Khuu C, Nirvani M, Utheim TP and Sehic A: MicroRNAs: Modulators of Tooth Development; Microrna. 2016;5(2):132-139.
68. Sehic S, Tulek A, Khuu C, Nirvani M and Utheim TP: MicroRNAs in Human Dental Tissues; The Role in Development and Disease, Microrna. 2016;5(2):132-139.
69. Sehic A, Guo S, Kinsang C, Corraya M, Chen DF, Utheim TP: Electrical stimulation as a mean of improving vision. Am J Pathol. 2016 Nov;186(11):2783-2797.
70. Pasovic, L, Eidet JR, Olstad OK, Lyberg T, Chen DF, Utheim TP: Impact of Storage Temperature on the Expression of Cell Survival Genes in Cultured ARPE-19 Cells, Curr Eye Res. 2017 Jan;42(1):134-144
71. Sehic A, Tulek A, Khuu C, Nirvani M, Sand LP, Utheim TP: Regulatory roles of microRNAs in human dental tissues. Gene. 2017 Jan 5;596:9-18. doi: 10.1016
72. Nirvani M, Khuu C, Utheim TP, Hollingen HS, Amundsen SF, Sehic A: Circadian Rhythms and Gene Expression During Mouse Molar Tooth Development, Acta Odontol Scand. 2017 Mar;75(2):144-153
73. Islam R, Eidet JR, Badian R, Lippestad M, Messelt E, Griffith M, Dartt DA, Utheim TP:
Tissue Harvesting Site and Culture Medium Affect Attachment, Growth and Phenotype of Ex Vivo Expanded Oral Mucosal Epithelial Cells, Sci Rep. 2017 Apr 6;7(1):674
74. Jackson C, Eidet JR, Reppe J, Eide L, Tønseth KA, Bergersen L, Dartt DA, Griffith M, and Utheim TP: Optimization of Storage Temperature for Retention of Undifferentiated Cell Character of Cultured Epidermal Cell Sheets, Sci Rep. 2017 Aug 15;7(1):8206
75. Aqrawi L, Galtung H, Vestad B, Øvstebø R, Thiede B, Rusthen S, Young Vik A, Guerreiro E, Utheim TP, Chen X, Utheim OA, Palm Ø, Jensen JL: Identification of potential saliva and tear biomarkers in primary Sjögren’s syndrome, utilising the extraction of extracellular vesicles and proteomics analysis, Arthritis Res Ther. 2017 Jan 25;19(1):14.
76. Chen X, Stojanovic A, Xu Y, Zhou W, Raeder S, Enayati S, Utheim TP: Long-Term Results of Corneal Cross-Linking for Keratoconus Using Phototherapeutic Keratectomy For Epithelial Removal and Minimal Stromal Ablation, J Refract Surg. 2017 Jul 1;33(7):488-495
77. Jackson C, Tønseth A, Utheim TP: Cultured Epidermal Stem Cells in Regenerative Medicine, Stem Cell Research & Therapy, Stem Cell Res Ther. 2017 Jul 4;8
78. Lippestad M, Hodges R, Utheim TP, Serhan CS, and Dartt DA: Resolvin D1 Increases Mucin Secretion in Cultured Rat Conjunctival Goblet Cells through Multiple Signaling Pathways, Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4530-4544.
79. Tashbayev B, Rusthen S, Chen X, Utheim O, Young A, Herlofson BB, Utheim TP, Jensen JL: Interdisciplinary, Comprehensive Oral and Ocular Evaluation of Patients with Primary Sjögren’s Syndrome, Sci Rep. 2017 Sep 7;7(1):10761.
80. Lagali N, Allgeier S, Guimarães P, Badian R, Ruggeri A, Köhler B, Utheim TP, Peebo B, Peterson M, Dahlin L, Rolandsson O: Decline in mosaic corneal nerve fiber density with duration of type 2 diabetes in an age-controlled cohort,Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6318-6327.
82. Chen X, Utheim OA, J, Adil MY, Stojanovic A, Tashbayev B, Jensen JL, Utheim TP: Evaluation of Dry Eye and Meibomian Gland Features in A Norwegian Cohort of Patients with Primary Sjögren´s Syndrome PLoS One. 2017 Sep 8;12(9):e0184284
83. Landsend ES, Utheim OA, Pedersen HR, Lagali N, Baraas RC, Utheim TP: The Genetics of Aniridia - A Guide to the Ophthalmologists, Surv Ophthalmol. 2018 Jan - Feb;63(1):105-113. doi: 10.1016/
84. Utheim TP, Utheim O, Salvanos P, Jackson C, Schrader S, Geerling G,  Sehic A:
Altered Versus Unaltered Amniotic Membrane as a Substrate for Limbal Epithelial Cells Stem Cells Transl Med. 2018 Mar 23. doi: 10.1002/sctm.17-0257
85. Landsend ES, Pedersen HR, Utheim OA, MD, Xiao J, Muhammed A, Tashbayev B, Lagali N, Dartt DA, Baraas RC, Utheim TP: Meibomian gland dysfunction and keratopathy are associated with dry eye disease in aniridia. Br J Ophthalmol. 2018 Mar 8
86. Aabel P, Utheim TP, Olstad OK; Rask-Andersen H; Dilley RJ; von Unge M: Transcription and microRNA profiling of cultured human tympanic membrane epidermal keratinocytes. J Assoc Res Otolaryngol. 2018 Apr 5. doi: 10.1007/s10162-018-0660-1.
87. Guo G, Cho KS, Tchedre K, Ma J, Antolik C, Utheim TP, Huang XA, Chew J, Lashkari K, Malik MT, Chen DF: IGFBPL1 is an essential gatekeeper for IGF-1-induced axon growth signals, Sci Rep. 2018 Feb 1;8(1):2054. doi: 10.1038/s41598-018-20463-5.
88. Lagali N, Wowra B, Dobrowolski D,  Fagerholm P, Wylegala E. Stage-related central corneal epithelial transformation in congenital aniridia-associated keratopathy.
Ocul Surf. 2018 Jan;16(1):163-172. doi: 10.1016/j.jtos.2017.11.003.
89. Nirvani M, Khuu C, Utheim TP, Sand LP, Sehic A. Circadian clock and oral cancer.
Mol Clin Oncol. 2018 Feb;8(2):219-226. doi: 10.3892/mco.2017.1518. Epub 2017 Nov 27.
90. Khan AZ, Utheim TP, Reppe S, Sandvik L, Lyberg T, Roald B, Eidet JR: Optimization of Storage of Differentiated Human Retinal Pigment Epithelial Cells, Microsc Microanal. 2018 Apr;24(2):147-155.
91. Landsend ES, Pedersen H, Utheim OA, Hans Christian Aass, Tashbayev B, Lagali N, Dartt DA, Barass R, Utheim TP:  Tear Cytokine Profile in a Scandinavian Cohort of Congenital Aniridia (in press, IOVS)
92. Pedersen H, Hagen LA, Landsend ES, Gilson S, Gjelle JV, Utheim OA, Utheim TP, Neitz M, and Baraas R: Color Vision in Aniridia (in press, IOVS)
93. Pasovic L, Utheim TP, Reppe S, Khan A, Jackson CJ, Thiede B, Berg JP, Messelt E, Eidet JR: Improvement of Storage Medium for Cultured Human Retinal Pigment Epithelial Cells using Factorial Design, Sci Rep. 2018 Apr 9;8(1):5688.
94. Lagali N, Allgeier S, Guimarães P, Badian R, Ruggeri A, Köhler B, Utheim TP, Peebo B, Peterson M, Dahlin L, Rolandsson O: Rapid automated generation and analysis of wide-area depth-corrected subbasal nerve plexus mosaics in a clinical setting, Sci Data. 2018 Apr 24;5:180075.
95. Lippestad M, Hodges R, Utheim TP, Serhan C, Dartt DA: Signaling Pathways Activated by Resolvin E1 to Stimulate Mucin Secretion and Increase Intracellular Ca2+ in Cultured Rat Conjunctival Goblet Cells, Exp Eye Res. 2018 Apr 25;173:64-72.
96. Utheim OA, Lyberg T, Eidet JR, Sehic A, Raeder S, Roald B, de la Paz M, Dartt DA, Utheim TP: Transportation of Cultured Limbal Epithelial Sheets for Worldwide Treatment of Limbal Stem Cell Deficiency (in press)
97. Brejchovaa K, Trosana P, Studenyc P, Skalickaa P, Utheime TP, Bednarb J, Jirsovab K: Characterization and Comparison of Human Limbal Explant Cultures Grown Under Defined and Xeno-Free Conditions (in press)
98. He M, Lippestad M, Li D, Hodges R, Utheim TP and Dartt DA:
Activation of the EGF Receptor by Histamine Receptor Subtypes Stimulates Mucin Secretion in Conjunctival Goblet Cells (in press)
99. Yazdani M, Chen X, Tashbayev B, Ræder S, Utheim OA, Stojanovic S, Lagali N, Dartt DA, Utheim TP: Tear production levels and dry eye disease severity in a large Norwegian cohort (in press)
100. Lagali N, Badian RA, Liu X, Feldreich TR, Ärnlöv J, Utheim TP, Dahlin LB, and Rolandsson O: Dendritic cell maturation in the corneal epithelium with onset of type 2 diabetes is associated with tumor necrosis factor receptor superfamily member 9 (in press)
101. Lång E, Polec A, Lång A, Blicher P, Rowe AD, Tønseth KA, Jackson C, Utheim TP, Eriksson JE, Bøe SO: Coordinated Collective Migration and Oriented Nuclear Partitioning in Sheets of Cultured Human Keratinocytes (Nature Communications, in press)
Submitted or in revision
Kosmina R, Utheim TP, Tønseth KA, Schoyen T, Reppe S, Edin N, Sandvik JA, Sehic A, Bergersen LH, Jackson C. Hypoxia Favors Maintenance of Undifferentiated Cell Phenotype During One-Week Storage of Cultured Epidermal Cell Sheets (revision)
Khan AK, Utheim TP, Reppe S, Olstad OK, Thiede B, Eidet JR: Proteomic Characterization of Human Retinal Pigment Epithelium Cultured with Sericin (submitted)
Xiao J, Muhammed YA, Olafsson J, Chen X, Lagali N, Raeder S, Utheim OA, Dartt DA, Utheim TP: Development and Evaluation of A Novel Meiboscore for Meibography Analysis of Dry Eye Disease (submitted)
Yazdani M, Chen X, Tashbayev B, Ræder S, Eidet JR, Utheim OA, Stojanovic S, Hua Y, Dartt DA, Utheim TP: Evaluation of the ocular surface disease index questionnaire as a predictive test for clinical findings in dry eye disease patients (submitted)
Badian R, Utheim TP, Chen X, Utheim OA, Ræder S, Ystenas A, Aakre BM, Sundling V: Prevalence of Meibomian Gland Dysfunction in a Norwegian Cohort of Dry Eye Patients (submitted)
Aabel P; Thiede B; Nilsen HL; Nygård S; Rask-Andersen H; Tønseth KA, James RD; Utheim TP; von Unge M: Quantitative Proteome Analysis of Cultured Human Tympanic Membrane Keratinocytes
Reppe S, Jackson C, Ringstad H, Tønseth KA, Bakke H, Eidet JR, Utheim TP: High Throughput Screening of Additives using Factorial Design to Promote Survival of Stored Undifferentiated Epidermal Cells (revision)
Olstad OK, Gautvik VT, LeBlanc M, Kvernevik K, Utheim TP, Runningen A, Wiik H, Kirkegaard C, Raastad T, Reppe S, Gautvik K: Patients with postmenopausal osteoporosis share common bone and skeletal muscle disease gene expression patterns that are improved by physical intervention (submitted)
Adil MY, Xiao J, Olafsson J, Chen X, Lagali N, Ræder S, Utheim OA, Dartt DA, Utheim TP: Meibomian Gland Morphology is a Sensitive Early Indicator of Meibomian Gland Dysfunction (submitted)
Hua Y, Wu Q, Utheim TP, Pan C, Wang Q: Analysis of the Changing Amount of Corneal Parameters and Spherical Equivalent after Myopic Keratorefractive Surgery (submitted)
Tashbayev B, Badian R, Chen X, Ræder S, Sundling V, Eidet JR, Utheim OA, Stojanovic A, Aakre BM, Bruenech J, Ystenæs AE, Utheim TP: Treatment Effects in Meibomian Gland Dysfunction in a Norwegian Cohort of Dry Eye Patients (revision)
Landsend ES, Utheim OA, Pedersen HR, Baraas RC, Lagali N, Bragadóttir R, Moe MC, Utheim TP: Fundus Autofluorescence in Congenital Aniridia (submitted)
Nirvani M; Khuu C; Tulek A; Utheim TP; Sand LP; Snead ML; Sehic A: Transcriptomic Analysis of MicroRNA Expression in Enamel-Producing Cells (submitted)
Tulek A, Saeed M, Mulic A, Stenhagen K, Utheim TP, Galtung HK, Khuu C, Nirvani M, Kristiansen MS og Sehic A: New Animal Model of Extrinsic Dental Erosion
Thomseth V, Cejvanovic V, Jimenez-Solem E, Poulsen HR, Utheim TP, Andersen JT:
Exposure to antazoline-naphazoline eye drops during pregnancy and the risk of congenital malformations: A Danish nationwide cohort study (submitted)
Papers in Nordic Journals or Books (7 in total):
1. Sten Ræder, Utheim TP, and Utheim OA: Ophthalmology – basal clinical examination, Unipub, Oslo, Norway, 2012 (book of 133 pages; distributed to thousands of medical students in Norway and abroad since 2008)
2. Rygh M, Utheim TP, Ræder S: Utposten [Dry Eyes], (Norwegian Medical Journal), 2013
3. Eidet JR, Utheim TP: [Treatment of Conjunctival Disorders with Transplantation], Oftalmolog, Issue 3, 2013, 6-7
4. Utheim TP, Utheim OA, Reader S, Lyberg T, Eidet JR: [Treatment of Limbal Stem Cell Deficiency – What is possible in 2014?], Oftalmolog (Nordic Journal of Ophthalmology), 2014, 4, pp.3-6
5. Utheim TP, Utheim OA, Raeder S, Messelt E, Eidet JR: The role of mucosal cells in treating blindness (review) Oftalmolog, March 2015.
6. Utheim TP, Sommer-Landsend E, Utheim OA: Aniridia (review) Oftalmolog, March 2015
7. Utheim TP, Utheim OA, Eidet JR, Raeder S, Jackson C, Sehic A: Transplantation of Skin to the Eye – What is the Status 122 Years after the First Transplantation? - Oftalmolog, September; December, 2015; (4) 17-19
Abstracts:
Presentations at Professional Meetings (Published in Peer-reviewed Journals)
1. Raeder S, Utheim TP, Ramstad H, Cai Y, Stoelen S, Baerland TP, Utheim OA, Messelt E, Lyberg T, Nicolaissen B: Engineering of Multilayered Polarized Epithelial Grafts From Explant Culture Is Independent of Limbal Explant Orientation. Invest. Ophthalmol. Vis. Sci. 2006 47: E-Abstract 3017
2. Utheim TP, Raeder S, Utheim OA, et al. Storage of Cultured Limbal Epithelial Cells at 23ºC and 31ºC in Organ Culture Medium and at 5ºC in Optisol-GS: A Light Microscopy and Phenotypic Study. Invest. Ophthalmol. Vis. Sci. 2007 48: E-Abstract 460
3. Prabhakar S, Utheim TP, Raeder S, et al. Apoptosis Gene Expression Profiling of Ex Vivo Expanded Human Limbal Epithelial Cells. The FASEB Journal 2007;21:lb56
4. Raeder S, Utheim TP, Utheim OA, et al. Eye Bank Storage of Cultured Corneal Epithelium: Sterility Testing of Storage Media, Long-Term Preservation, and Deepithelialization of the Amniotic Membrane Substrate Invest. Ophthalmol. Vis. Sci. 2008 47: E-Abstract 5717
5. Utheim TP, Raeder S, Utheim OA, et al. Identification of Predilection Target Sites for Tissue Harvesting in Corneal Epithelial Tissue Engineering Ophthalmol. Vis. Sci. 2008 47: E-Abstract 5746
6. Utheim TP, Raeder S, Eide JR, et al. Storage of Cultured Human Limbal Epithelial Cells in Optisol-GS at 23°C versus 5°C Invest. Ophthalmol. Vis. Sci. 2009 E-abstract 1778
7. Raeder S, Utheim TP, Olstad OK, et al. Genome-Wide Transcriptional Analysis of Cultured Human Limbal Epithelial Cells Following Hypothermic Storage in Optisol-GS Invest. Ophthalmol. Vis. Sci. 2009 E-abstract 1773
8. Eidet J, Fostad IG, Shatos M, Utheim TP et al. Effect of Biopsy Location and Size on Phenotype and Proliferative Ability of Cultured Rat Conjunctival Tissue. Invest. Ophthalmol. Vis. Sci. 2010 E-abstract 1912
9. Engelsvold DH, Ulltveit-Moe HF, Olstad OK, Utheim TP, et al: The MicroRNA And MessengerRNA Gene Expression Signature Of Human Primary Pterygium, ARVO 2011
10. Ulltveit-Moe HF, Eidet JR, Björkblom B, Møller S, Utheim TP, et al: Xenobiotic- and Serum-Free Culture Protocol for Autologous Cultivated Oral Mucosal Epithelial Cells on
Contact Lenses, ARVO 2011
11. Utheim TP, Utheim OA, Eidet J et al: Comparison of Storage of Cultured Human Limbal Epithelial Cells in HEPES-MEM, Optisol-GS and PAA Quantum 286 for 4 days at 23°C, ARVO 2011
12. Pasovic L, Eidet JR, Aabel P, Messelt E, Lyberg T, Chen X, and Utheim TP. Effect of storage temperature on the viability of cultured retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 2012 E-abstract
13. Prener JP, Eidet JR, Utheim TP; Bragadottir R. Ultra-Widefield Retinal Autofluorescence Patterns in Patients with Autosomal Dominant Retinitis Pigmentosa and Stargardt’s Disease. Invest. Ophthalmol. Vis. Sci. 2012 E-abstract
14. Chen X, Stojanovic A, Zheng L, Zhang J, Stojanovic F, Wang Q, Utheim TP. One-step transepithelial topography-guided ablation in treatment of myopic astigmatism. Invest. Ophthalmol. Vis. Sci. 2012 E-abstract
15. Utheim TP, Utheim OA, Eidet JR, de la Paz M, Messelt E, Roald B, Dartt DA, Lyberg T. Transportation simulations of cultured human limbal epithelial cells subjected to eye-bank storage. Invest. Ophthalmol. Vis. Sci. 2012 E-abstract
16. Utheim TP, Edén U, Lagali N, Dellby A, Riise R, Chen X, Fagerholm P: In Vivo Morphology of the Limbal Palisades of Vogt Correlates with Progressive Stem Cell Deficiency in Aniridia-Related Keratopathy. Invest. Ophthalmol. Vis. Sci. 2013 E-abstract
17. Storr-Paulsen T; Fullana M; Wang A; Karamichos D; Utheim TP; Shatos MA; Hjortdal J; Wnek GE; Dartt DA: Use of Polymeric Scaffolds as Extracellular Matrix Substitutes for Conjunctival Epithelial Repair. Invest. Ophthalmol. Vis. Sci. 2013 E-abstract
18. Rygh OM; Eidet JR; Chen X; Utheim TP, Thyholdt A; Utheim OA; Stojanovic F; Stojanovic A; Raeder S: Symptoms and Findings in a Norwegian Cohort of Patients with Meibomian Gland Dysfunction. Invest. Ophthalmol. Vis. Sci. 2013 E-abstract
19. Eidet JR, Utheim TP, Utheim OA, Chen X, Stojanovic A, Dartt DA, Raeder S Improved Staining, Tear Film Breakup Time, and Dry Eye Severity Level Following a Six-Month Treatment of a Cohort of Dry Eye Patients in Norway. Invest. Ophthalmol. Vis. Sci. 2014 E-abstract
20. Badian R, Raeder S , Utheim TP, Utheim OA, Chen X, Stojanovic A, Dartt DA, Eidet JR.  Age-associated Differences in Severity of Ocular Signs in Dry Eye Disease Patients Invest. Ophthalmol. Vis. Sci. 2014 E-abstract
21.  Fostad I, Eidet JR, Raeder S, Lagali N, Messelt E, Jensen J, Galtung H, Utheim TP: Dry Eye Disease Patients with Xerostomia Report Higher Symptomatic Burden. Invest. Ophthalmol. Vis. Sci. 2014 E-abstract
22. Salvanos P, Utheim TP, Moe MC, Eide N, Bragadottir R: Autofluorescence Pattern of Optic Disc Melanocytoma. Invest. Ophthalmol. Vis. Sci. 2014 E-abstract
23. Parissi M, Randjelovic S, Wihlmark TB, Utheim TP, and Lagali N: Corneal subbasal nerve morphology and regeneration in keratoconus and 4 years after UVA-riboflavin collagen cross-linking. Invest. Ophthalmol. Vis. Sci. 2014 E-abstract
24. Utheim TP, Fricke O, Lagali N: Distinct ‘microdot’ structures accumulate in the cornea with age. Invest. Ophthalmol. Vis. Sci. 2014 E-abstract
25. Jackson C, Aabel P, Eidet JR, Messelt E, Lyberg T, Utheim TP: Xenobiotic Free Storage of Cultured Epidermal Cell Sheets for 14 Days – the Effects of Temperature on Viability, Morphology, Phenotype and Metabolic status. Invest. Ophthalmol. Vis. Sci. 2014 E-abstract
26. Lippestad M, Hodges RR, Utheim TP, Serhan CH, and Dartt DA: RvD1 and RvE1 in Epithelial Goblet Cell Function, New York Academy of Science Conference, New York, U.S., 2014
27. Islam R, Utheim TP, Eidet JR, Lippestad M, Messelt E, Griffith M, Dartt DA. Clonal Growth Capacity and Phenotype of Ex Vivo Expanded Oral Mucosal Tissue. Experimental Biology conference, San Diego, 2014
28. Lippestad M, Hodges RR, Utheim TP, Serhan CH, and Dartt DA: Differential Effect of Pro-resolution Mediators Resolvins RvD1 and RvE1 on Conjunctival Goblet Cell Function. ARVO, US, 2014
29. Islam R, Utheim TP, Eidet JR, Lippestad M, Messelt E, Griffith M, Dartt DA: Culture Media and Biopsy Location Effect the Proliferative Capacity and Phenotype of Ex Vivo Expanded Oral Mucosal Tissue. ARVO, US, 2014
30. Badian R, Utheim TP, Allgeier S, Köhler, B; Ruggeri, A, Poletti E, Guimarães P, Lagali S: Quantitative Analysis of Corneal Sub-basal Nerve Plexus and Inflammatory Cells in Large-area Mosaics Obtained by In Vivo Confocal Microscopy ARVO, US, 2014
31. Utheim TP, Islam R, Fostad I, Dartt DA, Olstad OK, Sehic A, Eidet JR: Impact of Storage Temperature on Gene Expression of Cultured Oral Mucosal Cells, ARVO, US, 2014
32. Utheim TP, Utheim OA, Raeder S, Lyberg T, Messelt E, Jackson C, Islam R, Eidet JR:  Stem Cell Therapy of the Ocular Surface – Current Possibilities and Limitations: Kongsberg Vision Meeting, Kongsberg, Norway, 2014 (oral presentation)
33.  Fostad, IG; Eidet JR, Lyberg T, Olstad OK, Utheim TP, Mikkelsen K; Wiik A, Hollan A The Increased Risk of Cardiovascular Disease in Rheumatoid Arthritis may be related to Nupr1 activation: EULAR Conference, Zürich, Switzerland, 2015 Annals of the Rheumatic Diseases (Impact Factor: 10.38) 06/2015; 74(Suppl 2):686.1-686. 10.38:
34. Eidet JR, Utheim TP, Lyberg T, Kaass A, Mikkelsen K, Veel T, Saatvedt, Fagerland MW, Hollan I: Level of adiponectin in rheumatoid arthritis is associated with coronary artery disease, EULAR Conference, Zürich, Switzerland, 2015, Publication in Annals of the Rheumatic Diseases (Impact Factor: 10.38). 06/2015; 74(Suppl 2):449.2-450.
35. Utheim TP, Wendel J, Jackson C, lslam R, Ræder S, Sehic A, Eidet JR: Innovative strategies for treating stem cell deficiency of the ocular surface, Kongsberg Vision Meeting 2015 (submitted)
36. Badian R, Utheim TP, Raeder S, Utheim OA, Chen X, Stojanovic A, Eidet JR. Effects of contact lens use in a cohort of dry eye disease patients. Kongsberg Vision Meeting 2015 (submitted)
37. Jackson C, Eidet JR, Reppe S, Eide L, Tønseth KA, Bergesen LR,  Dartt DA, Griffith M, and Utheim TP: Optimization of Storage Temperature for Retention of Undifferentiated Cell Character of Cultured Human Epidermal Cell Sheets. Kongsberg Vision Meeting 2015
38. Rakibul Islam, Darlene A. Dartt, Jon R. Eidet, Marit Lippestad, Edward Messelt, May Griffith, Tor P. Utheim: The effects of culture parameters on ex vivo expansion of oral mucosal cells. Kongsberg Vision Meeting 2015
39. Eidet JR, Ræder S, Chen X, Badian RA, Utheim OA, Utheim TP: The Four Seasons of Dry Eye Disease Seasonal Variations in Presenting Symptoms and Signs of Dry Eye Disease in Norway (European Association for Vision and Research, Nice, October 7-10, 2015)
40. Badian, Utheim, Allgeie S, Köhler R, Lagali N: Quantitative analysis of Central Corneal Sub-basal Inflammatory cells/Dendritic Cells in Large-area Mosaic images obtained by In Vivo Confocal Microscopy (IVCM), Invest. Ophthalmol. Vis. Sci. 2016 E-abstract,
41 Reppe, Chen X, Raeder S, Utheim TP, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Tashbayev B: Clinical Findings of Dry Eye Disease in a Large Norwegian Cohort Based on Osmolarity Measurements Invest. Ophthalmol. Vis. Sci. 2016 E-abstract
42. Eidet JR, Ræder S, Chen X, Badian RA, Utheim OA, Utheim TP: Dry Eye Disease Therapy: who are the non-responders? (European Association for Vision and Research, Nice, October 7-10, 2015)
43. Utheim OA, Ræder S, Eidet JR, Utheim TP, Badian RA, Stojanovic A, Chen X: Efficacy of Dry Eye Disease Treatment based on the 2007 Report of the International Dry Eye WorkShop (DEWS) (European Association for Vision and Research, Nice, October 7-10, 2015)
44. Badian R, Eidet JR, Ræder S, Utheim OA, Chen X, Stojanovic A, Utheim TP: Correlation of Osmolarity Measurements with Signs and Symptoms in a Norwegian Cohort of Patients with Dry Eye Disease (European Association for Vision and Research, Nice, October 7-10, 2015)
45. Badian R, Eidet JR, Ræder S, Utheim OA, Chen X, Stojanovic A, Utheim TP: Advancing age does not strongly correlate with symptoms and signs of Dry Eye Disease in a large Norwegian cohort (European Association for Vision and Research, Nice, October 7-10, 2015)
46. Pasovic L, Utheim TP, Reppe S, Lyberg T, Olstad OK, and Eidet JR: The Silk-protein Sericin Induces Rapid Melanization of Cultured Retinal Pigment Epithelial Cells by Activating the NF-B Pathway (European Association for Vision and Research, Nice, October 7-10, 2015)
47. Pasovic L, Eidet JR, Olstad OK, Chen DF, Lyberg T and Utheim TP:
Impact of Storage Temperature on Gene Expression of Cultured ARPE-19 Cells (European Association for Vision and Research, Nice, October 7-10, 2015)
48. Eidet  JR, Fostad IG, Shields K, Lyberg  T, Utheim TP,  Kåss  A,  Mikkelsen  K, Veel T,  Saatvedt K, Fagerland M, Liang M, Hollan I: A low adiponectin level in rheumatoid arthritis is associated with coronary artery disease; ACR/ARHP Annual Meeting, San Francisco, CA; November 6-11, 2015
49. Fostad IG, Eidet JR, Lyberg T, Olstad OK, Utheim TP, Mikkelsen K, Wiik A, Hollan I. The Transcription Factor NUPR1 may Contribute to Increased Risk of Cardiovascular Disease in Patients With Rheumatoid Arthritis; ACR/ARHP Annual Meeting, San Francisco, CA; November 6-11, 2015
50. Jackson C, Tashbayev B, Raeder S, Utheim TP, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Chen X: Treatment Effects in a Norwegian Cohort of Dry Eye Patients with Meibomian Gland Dysfunction Following Treatment According to Guidelines Presented at The International Workshop on Meibomian Gland Dysfunction (2011): Three and Six Months Follow-up, Invest. Ophthalmol. Vis. Sci. 2016 E-abstract
51. Mohammed A, Xiao J, Olafsson J, Raeder S, Utheim TP, Utheim OA, Lagali N, Dartt DA, Chen X: Subjective and Objective Assessment of Meibography Images Invest. Ophthalmol. Vis. Sci. 2016 E-abstract
52. Landsend E, Utheim OA, Pedersen H, Baraas R, Dartt DA, Lagali N, Utheim TP: Dry Eye Disease in a Norwegian-Danish Cohort of Congenital Aniridia, Invest. Ophthalmol. Vis. Sci. 2016 E-abstract
53. Xiao J, Mohammed A, Olafsson J, Raeder S, Utheim TP, Utheim OA, Lagali N, Dartt DA, Chen X: Morphological Evaluation of Meibomian Glands in Eyes with Dry Eye Disease, Invest. Ophthalmol. Vis. Sci. 2016 E-abstract
54. Pedersen H, Hagen LA, Landsend E, Gjelle J, Utheim OA, Gilson SJ, Utheim TP, Baraas R. Color vision, dark adaptation and retinal structure in Aniridia, Invest. Ophthalmol. Vis. Sci. 2016 E-abstract
55. Eidet JR, Tashbayev B,Chen X, Ræder S, Badian R, Utheim OA, Fostad IG, Dartt DA, Utheim TP: Pollen Count Compared with Severity of Symptoms and Signs of Dry Eye Disease in Norway, EVER, October 5-8, 2016
56. Khan A, Utheim TP, Reppe S, Sandvik L, Lyberg T, Roald B, Eidet JR: Optimization of Storage of Differentiated Retinal Pigment Epithelial Cells, EVER, October 5-8, 2016
57. Reppe, Chen X, Raeder S, Utheim TP, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Tashbayev B: Clinical Findings of Dry Eye Disease in a Large Norwegian Cohort Based on Osmolarity Measurements Invest. Ophthalmol. Vis. Sci. 2016 E-abstract
58. Tashbayev B, Chen X, Raeder S, Utheim OA, Stojanovic A, Utheim TP: Correlation between clinical parameters from the right and left eyes of a Norwegian cohort of dry eye patients, Kongsberg Vision Meeting 2016, Norway
59. Chen X, Stojanovic A, Raeder S, Utheim TP: Medium- to Long-Term Results of Corneal Cross-Linking for Keratoconus Using Phototherapeutic Keratectomy for Epithelial Removal and Partial Stromal Ablation, Kongsberg Vision Meeting 2016, Norway
60. Xu Y, Chen X, Zhou W, Utheim TP, Stojanovic A: Comparison of Pachymetry Measurements Using Two Optical Coherence Tomography Devices and Rotating Scheimpflug Imaging in Eyes with Keratoconus, ESCRS, 2016
61. Lagali N, Wowra B, Darek T, Utheim TP, Wylegala E, Fagerholm P: The progressive phenotype of aniridia-associated keratopathy in a Polish cohort – therapeutic implications, ARVO, Baltimore, US, 2017
62. Badian R, Utheim TP, Allgeier S, Liu X, Köhler B, Lagali N: Quantification of Inflammatory Cells in the Corneal Sub-basal Layer in Type 2 Diabetes by In Vivo Confocal Microscopy (IVCM), ARVO, Baltimore, US, 2017
63. Dartt DA, Botten N, Hodges R, Dayu L, Bair  J, Shatos M, Utheim TP, Serhan CN: Resolvin D2 Increases Conjunctival Goblet Cell Intracellular [Ca2+] by Increasing Cellular cAMP Levels and Activating Protein Kinase A, ARVO, Baltimore, US, 2017
64. Tashbayev B, Rusthen S, Chen X, Utheim O, Young A, Herlofson BB, Utheim TP, Jensen JL Interdisciplinary evaluation of patients with primary sjögren’s syndrome. ARVO, Baltimore, US, 2017
65. Landsend ES, Pedersen H, Utheim OA, Hans Christian Aass, Tashbayev B, Lagali N, Dartt DA, Barass R, Utheim TP: Tear Cytokine Profile in a Scandinavian Cohort of Congenital Aniridia: ARVO, Baltimore, US, 2017
66. Cho KS, Xiao J, Adil MY, Utheim, TP, Chen, DF:
Contrast sensitivity threshold correlates to the progressive degeneration of photoreceptors in a mouse model of retinitis pigmentosa.
ARVO, Baltimore, US, 2017
67. Tashbayev B, Raeder S, Chen X, Stojanovic A, Utheim OA, Utheim TP: Utility of tear osmolarity measurement in diagnosis of dry eye disease; European Society of Ophthalmolgy, June 2017
68. Fjærvoll K, Yazdani M, Utheim TP, Utheim OA Chen X, Ræder S, Tashbayev B: Preservative-Free Eye Drops for Dry Eye Disease! How about Eye Cosmetics?! - Kongsberg Vision Meeting, October 24-26, 2017, Kongsberg, Norway
69. Fjærvoll H, Yazdani M, Utheim TP, Utheim OA Chen X, Ræder S, Tashbayev B: Eye Cosmetic Products and a Known Eye Irritant - Kongsberg Vision Meeting, October 24-26, 2017, Kongsberg, Norway
70. Raja SI, Utheim TP, Utheim OA Chen X, Ræder S, Tashbayev B: Tear Osmolarity Measurements in a Norwegian Cohort of Patients with Clinically Evident Dry Eye Disease - Kongsberg Vision Meeting, October 24-26, 2017, Kongsberg, Norway
71. Olafsson J, Utheim TP, Utheim OA Chen X, Ræder S, Tashbayev B: Interocular Difference in Tear Film Break-up Time in a Norwegian Cohort of Dry Eye Patients - Kongsberg Vision Meeting, October 24-26, 2017, Kongsberg, Norway
72. Kaurstad M, Utheim OA, Chen X, Utheim TP, Ræder S, Tashbayev B: Characteristics of Dry Eye Disease in Two Different Age Groups in a Norwegian Cohort of Dry Eye Patients, Kongsberg Vision Meeting, October 24-26, 2017, Kongsberg, Norway
73. Espelid I, Utheim TP, Xiangjun Chen, Ræder S, Utheim OA, Dartt DA, Tashbayev B: Assessment of Dry Eye Related Quality of Life in a Norwegian Cohort of Dry Eye Patients, Kongsberg Vision Meeting, October 24-26, 2017, Kongsberg, Norway
74. Yazdani M, Chen X, Tashbayev B, Utheim OA, Ræder S, Lagli N, Stojanovic A, Dartt DA, Utheim TP: Tear production levels and dry eye disease severity in a large Norwegian cohort - Kongsberg Vision Meeting, October 24-26, 2017, Kongsberg, Norway
75. Tellefsen S, Stojanovic A, Utheim TP, Tashbayev B, Raeder S, Chen X: Gender differences in symptoms and signs of dry eye disease in patients under 40 years old - Kongsberg Vision Meeting, October 24-26, 2017, Kongsberg, Norway
76. Tashbayev B, Rusthen S, Chen X, Utheim TP, Utheim Ø, Young A, Herlofson BB, Aqrawi LA, Rykke M, Hove LH, Palm Ø, Jensen JL: Dry Mouth and Dry Eye Examinations of a Norwegian Cohort of Primary Sjögren´s Syndrome Patients, The 64th Congress of the European Organisation for Caries Research 2017, Oslo, Norway
77. Hilde R. Pedersen, Jon V. Gjelle, Lene A. Hagen, Erlend C. Landsend, Stuart J. Gilson, Øygunn A. Utheim, Tor P. Utheim, Rigmor C. Baraas: Investigations of ocular biometry in patients with congenital aniridia. Kongsberg Vision Meeting, Kongsberg, Norway
78. Badian RA, Utheim TP, Ræder S, Utheim ØA, Chen X, Tashbayev B, Aakre BM,  Ystenæs AE, Sundling V: Title: Prevalence of MGD in a Norwegian Working Age Population Seeking Specialist Eye Care for Dry Eye Symptoms; ARVO, Hawaii, April 29 - May 3, 2018
79. Olafsson, J; Utheim, OA, Chen, X; Olafsson, S; Raeder, S; Dartt DA; Tashbayev B; Utheim, TP: Changes in Signs and Symptoms of Dry Eye Disease after using 0.1% and 0.05% Emulsions of Cyclosporine A Eye Drops; ARVO, Hawaii, April 29 - May 3, 2018
80. Reppe S, Jackson CJ, Ringstad H, Bakke H, Tønseth KA, Eidet JR, Utheim TP: Factorial design in regenerative medicine – high throughput screening of additives to promote survival of stored undifferentiated epidermal cells; ARVO, Hawaii, April 29 - May 3, 2018
81. Jackson CJ, Yazdani M, Reppe S, Tønseth KA, Thiede B, Utheim TP: Proteomic Analysis Indicates Activation of Cell Protective and Energy Conservation Mechanisms in Cultured Sheets Stored at 12°C: ARVO, Hawaii, April 29 - May 3, 2018
82. Enayati S, Cho K, Utheim TP, Chen DF: Electrostimulation promotes Muller glial cell proliferation: ARVO, Hawaii, April 29 - May 3, 2018
84. Pedersen H, Neitz J, Gilson SJ, Landsend ES, Utheim OA, Utheim TP, Baraas R: Retinal structure variation in congenital aniridia: within family phenotype-genotype discordance ARVO, Hawaii, April 29 - May 3, 2018
85. Landsend ES, Utheim OA, Pedersen HR, Baraas RC, Lagali N, Bragadóttir R, Moe MC, Utheim TP: Fundus Autofluorescence in Congenital Aniridia; ARVO, Hawaii, April 29 - May 3, 2018
86. Cho KS, Xiao J, Shi C, Chang K, Utheim TP, Luo G, Chen DF: Comparison of computerized system and human observers for vision assessment based on optomotor response in Rhodopsin knockout mice, ARVO, Hawaii, April 29 - May 3, 2018
87. Darlene Dartt, Marit Lippestad, Robin Hodges, Tor Utheim, Charles Serhan: Resolvin E1 uses multiple receptors and signaling pathways to increase intracellular Ca2+ and mucin secretion in conjunctival goblet cells, ARVO, Hawaii, April 29 - May 3, 2018
Presentations at Professional Meetings (not published)
1. Raeder S, Utheim TP, Ramstad H, Cai Y, Stoelen S, Pedersen TP, Utheim OA, Messelt E, Lyberg T, Nicolaissen B: Engineering of multilayered polarized corneal epithelial grafts from explant culture. XXXVII Nordic Congress of Ophtalmology, Copenhagen, Denmark 2006
2. Utheim TP, Ræder S, Utheim ØA, Cai Y, Roald B, Lyberg T, Kjeldsen-Kragh J, Ramstad H, Messelt E, Nicolaissen B: The effect of limbal explant orientation on the phenotype and barrier function of cultured limbal epithelial cells. European Eye Bank Association, XIX. Annual Meeting, Bratislava, Slovakia, 2007
3. Utheim TP, Raeder S, Utheim OA, Eidet JR, Roald B, Lyberg T: A novel method of preserving cultured limbal epithelial cells. European Eye Bank Association, XIX. Annual Meeting, Bratislava, Slovakia, 2007
4. Raeder S, Utheim TP, Utheim OA, et al. Effects of the size of explants on adhesion and outgrowth of ex vivo expanded limbal epithelial cells, XXXVIII Nordic Congress of Ophtalmology, Tromsoe, Norway, 2008
5. Raeder S, Utheim TP, Utheim OA, et al. The rationale of transplantation of preserved cultured limbal epithelial cells: Possibilities and limitations, XXXVIII Nordic Congress of Ophtalmology, Tromsoe, Norway, 2008
6. Utheim TP, Raeder S, Utheim OA, et al. Effects of the size of explants on epithelial thickness, number of cell layers, ultrastructure, and phenotype of cultured limbal epithelial cells. European Eye Bank Association, Annual Meeting, Amsterdam, The Netherlands, 2009
7. Eidet J, Utheim TP, Utheim OA, Lyberg T: Effects of ExtraCellular Matrix Proteins on Adhesion of Cultured Human Retinal Pigment Epithelial Cells, EVER 2010.
8. Utheim TP, Eidet J, Utheim OA, Lyberg T: Storage of Cultured Human Limbal Epithelial Cells in HEPES-MEM at 23°C, EVER 2010
9. Utheim TP Eidet JR, Utheim OA, Raeder S, Dartt DA, Roald B Carreras E, Huynh TH, Messelt E, Louch WE, Lyberg T. Effects of Serum-free Eye Banking on Morphology, Phenotype, and Viability of Ex Vivo Cultivated Human Conjunctival Epithelium, EUCornea, 2011
10. Lagali N, Eden U, Utheim TP, Chen X, Riise R, Dellby A, and Fagerholm P: Morphologic investigation of the limbal stem cell niche in aniridia by in vivo confocal microscopy, XXXX Nordic Congress of Ophtalmology NOK 2012, Helsinki
11. Edén U, Lagali N, Fagerholm P, Dellby A, Utheim TP, Riise R: Cataract, cataract surgery and Keratopathy in patients with congenital aniridia, XXXX Nordic Congress of Ophtalmology NOK 2012, Helsinki
12. Engelsvold D, Utheim TP,  Olstad OK, Lyberg T, Gonzalez P, Dartt DA. Raeder S:
MicroRNA And mRNA Gene Expression Signature Identifies miR-200 family as Potential Regulator of Epithelial-Mesenchymal Transition in Primary Pterygium, XXXX Nordic Congress of Ophtalmology NOK 2012, Helsinki
13. Utheim TP Raeder S, Utheim OA, Eidet JR, de la Paz M, Messelt E, Roald B, Dartt DA, Lyberg T.  Treating limbal stem cell deficiency without applying limbal stem cells 1st European Conference on Aniridia, Oslo, Norway, 2012
14. Utheim TP, Raeder S, Utheim OA, Eidet JR, de la Paz M, Messelt E, Roald B, Dartt DA, Lyberg T.:  Storage and transportation of cultured limbal and conjunctival epithelial cells for ocular surface reconstruction; 1st European Conference on Aniridia, Oslo, Norway, 2012
15. Eden U, Riise R, Tornquist K, Lagali N, Utheim TP, Chen X, Fagerholm P: How does the eye status in aniridia evolve with time? 1st European Conference on Aniridia, Oslo, Norway, 2012
16. Utheim TP, Utheim OA, Eidet JR, de la Paz M, Roald B, Dartt DA, Lyberg T. The impact of storage temperature and storage media on cultured human limbal epithelial cells, 5th Military Research Symposium on Ocular and Vision Injury, Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA, 2012
17. Utheim TP, Utheim OA, Eidet JR, Messelt E, de la Paz M, Roald B, Dartt DA, Lyberg T. A novel transportation system for cultured human limbal epithelial cells, 5th Military Research Symposium on Ocular and Vision Injury, Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA, 2012
18. Utheim TP, Pasovic L, Messelt E, Lyberg T, Chen DF, Aabel P, Chen X and Eidet JR Preservation of cultured human retinal epithelial cells, 5th Military Research Symposium on Ocular and Vision Injury, Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA, 2012
19. Utheim TP: The role of stem cells in ocular surface reconstruction" SOE Congress, Copenhagen, Denmark (SOE lecturer poster), 2013
20. Utheim TP, Eidet JR, Chen X, Utheim OA, Rygh OM, Thyholdt A, Stojanovic F, Stojanovic A, Raeder S: Comparison of symptoms and signs of Norwegian dry eye disease patients with and without meibomian gland dysfunction" SOE Congress, Copenhagen, Denmark, 2013
21. Chen X, Stojanovic A, Stojanovic F, Wang J, and Utheim TP: The contribution of the Posterior Corneal Surface to the Total Corneal Astigmatism XXXI Congress of the ESCRS, Amsterdam, The Netherlands, 2013
22. Chen X, Stojanovic A, Wang J, Hua Y, Jiang T, Zhang T and Utheim TP: Repeatability and Reproducibility of Corneal Biomechanical Measurement with Dynamic Scheimpflug Analyzer XXXI Congress of the ESCRS, Amsterdam, The Netherlands, 2013
23. Eidet JR, Chen X, Utheim TP, Utheim OA, Stojanovic A, Stojanovic F, Raeder S:  Correlations between severity of dry eye symptoms and the use of systemic prescription drugs in a cohort of dry eye patients. TFOS, Sicily, Italy, 2013
24. Badian R, Eidet JR, Raeder S, Utheim OA, Chen X, Stojanovic A, Utheim TP. Prevalence of Meibomian Gland Disorder in a Cohort of Norwegian Dry Eye Disease Patients, Nordic Congress of Ophthalmology, Stockholm, Sweden, 2014
25. Badian R, Utheim TP, Raeder S, Utheim OA, Chen X, Stojanovic A, Eidet JR. Contact lenses and dry eyes. Nordic Congress of Ophthalmology, Stockholm, Sweden, 2014
51. Badian R, Raeder S, Utheim TP, Utheim OA, Chen X, Stojanovic A, Eidet JR. Lower Vital Staining Score and Increased Tear Film Break-Up Time One Year After Initiation of Treatment of Dry Eye Disease. Nordic Congress of Ophthalmology, Stockholm, Sweden, 2014
26. Badian R, Raeder S, Utheim TP, Utheim OA, Chen X, Stojanovic A, Eidet JR. Ocular Protection Index is related to Ocular Surface Disease Index in Dry Eye Disease Patients European Association for Vision and Eye Research, Nice, France, 2014
27. Badian R, Raeder S, Utheim TP, Utheim OA, Chen X, Stojanovic A, Eidet JR. Evaluation of Self-report Questionnaires as Predictive Tests for Obtaining Pathological Schirmer I, Tear Film Break-up Time and Ocular Protection Index Scores in Dry Eye Disease Patients
European Association for Vision and Eye Research, Nice, France, 2014
28. Salvanos P., Bragadóttir R., Stene-Johansen I., Moe M.C., Utheim T.P.. Long-term follow-up of bomb explosion injury with fundus autofluorescence imaging. SOE2015, Vienna 6-9 June 2015
29. Utheim TP, Jackson C, Eidet JR, Messelt E, Corroya RM, Lyberg T, Griffith M, Dartt DA; Islam R:  Effect of Storage Temperature on the Viability, Phenotype, Metabolism and Morphology of Cultured Human Oral Keratinocytes, 2nd European Conference on Aniridia, Venice, Italy, 2014 (selected for oral presentation)
30. Jackson C, Aabel P, Eidet JR, Lyberg T, Messelt E, Utheim TP: Treating blindness by means of cultured epidermal cells. The Norwegian Ophthalmology Society, Oslo, Norway, 2014 (oral presentation)
31. Jackson C, Aabel P, Eidet JR, Messelt E, Lyberg T, Utheim TP: The rationale for transplanting epidermal cells onto the cornea to treat blindness - Latest progress in culture and storage of epidermal cells (oral presentation). Norwegian Center of Stem Cell Research, Oslo, Norway, 2014
32. Islam R, Utheim TP, Eidet JR, Lippestad M, Messelt E, Griffith M, Dartt DA. Effects of Culture Media and Biopsy Location on Proliferative Capacity and Phenotype of Ex Vivo Expanded Oral Mucosal Tissue: Cornea Center of Excellence Faculty Scientific Retreat, Harvard Medical School, Boston, US, 2014
33. Lippestad M, Hodges RR, Utheim TP, Serhan CH, and Dartt DA: Differential Effect of Pro-resolution Mediators Resolvins RvD1 and RvE1 on Conjunctival Goblet Cell Function: Cornea Center of Excellence Faculty Scientific Retreat, Harvard Medical School, Boston, US, 2014
34. Fagerholm P, Eden U, Lagali N, Dellby A, Ihnatko, Utheim TP, Chen X, Riise R: Aniridia Associated keratoplasty: Is it time to evaluate treatment? 2nd European Conference on Aniridia, Venice, Italy, 2014 (selected for oral presentation)
35. Fostad IG, Eidet JR, Ræder S, Messelt EB, Lagali NS, Dartt DA, Utheim TP. Identification of Objective Morphometric Markers of Xerostomia in the Oral Mucosal Epithelium of Dry Eye Disease Patients using In Vivo Confocal Microscopy, Digital Pathology Congress, London, 2014
36. Kahn A, Utheim, TP, Jackson C, Reppe S, Lyberg T, Eidet JR: Nucleus Morphometry in Cultured Epithelial Cells Correlates with Phenotype, Digital Pathology Congress, London, 2014
37. Chen X, Stojanovic A, Yang Z, Utheim TP. Corneal epithelial thickness profile changes after transepithelial surface ablation in treatment of myopia. XXXII European Society of Cataract & Refractive Surgeons, London, England, 2014
38. Salvanos P, Moe MC, Utheim TP, Bragadóttir R: Fundus autofluorescence in the evaluation of retinal detachment surgery. Rapid fire presentation, SOE2015, Vienna 6-9 June 2015 (selected for oral presentation)
39. Salvanos P, Stang Ø, Bragadóttir R, Utheim TP, Moe MC: Ophthalmological Complications after ball lightning injury. SOE2015, Vienna 6-9 June 2015
40. Salvanos P, Eide N, Moe MC, Utheim TP, Bragadóttir R: Retinal hemangioma in longstanding retinal detachment. SOE2015, Vienna 6-9 June 2015
41. Salvanos P, R. Øvergaard, Landsend E, Utheim TP, Moe MC, Bragadóttir R: Retinal Detachment from CSF leakage in Morning Glory Syndrome. SOE2015, Vienna 6-9 June 2015
42. Salvanos P, Moe MC, Utheim TP, Bragadottir R: Fundus autofluorescence in in optic disc melanocytoma SOE2015, Vienna 6-9 June 2015
43. Salvanos P, Ragnheidur B, Stene-Johansen I, Moe MC, Utheim TP: Long-term follow up of bomb explosion injury with fundus autofluorescence imaging SOE2015, Vienna 6-9 June 2015
44. Xiangjun Chen, Fostad IG, Utheim TP, Dartt DA, Ræder S, Messelt EB, Lagali NS, Eidet JR: Cell Nucleus Backscatter in the Conjunctival Epithelium is Associated with Dry Eye Severity Level (submitted)
45. Jackson C, Eidet JR, Eide L, Messelt E, Dartt DA, Griffith M, Bergersen LH, Utheim TP: Storage Temperature Affects Retention of Cell Integrity, Viability and Undifferentiated Cell Phenotype in Stored Cultured Epidermal Cell Sheets (oral presentation) - Norwegian Center of Stem Cell Research, Oslo, Norway, 2015
46. Salvanos P, Utheim TP Moe MC, Bragadottir R: Autofluorescence in Postoperative Evaluation of Amotio The Norwegian Ophthalmology Society, Oslo, Norway, 2014 (oral presentation)
47. Landsend ES, Utheim OA, Pedersen H, Baraas R, Tashbayev B, Lagali N, Dartt DA, Tor Paaske Utheim: Dry Eye Disease in a Norwegian-Danish Cohort of Congenital Aniridia, Gordon Conference, California, 2016
48. Landsend ES, Utheim OA, Adil MY, Pedersen H, Baraas R, Lagali N, Dartt DA, Utheim TP: Assessment of Meibography Images in a Norwegian-Danish Cohort of Congenital, Aniridia Gordon Conference, California, 2016
49. Nicolaissen BO, Tashbayev B, Raeder S, Utheim TP, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Chen X: Evaluation of the Dry Eye Ocular Surface Disease Index (OSDI) Questionnaire as a Predictive Test for Clinical Findings in Dry Eye Disease Patients, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016
50. Enayati S, Tashbayev B, Raeder S, Utheim TP, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Chen X Treatment Effects in Meibomian Gland Dysfunction in a Norwegian Cohort of Dry Eye Patients, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016
51. Borud I, Chen X, Raeder S, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Utheim TP: Clinical Findings in a Large Norwegian Cohort of Dry Eye Disease Based on Tear Production, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016
52. Salvanos P, Tashbayev B, Chen X, Raeder S, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Utheim TP Clinical Findings in a Large Norwegian Cohort of Dry Eye Disease Based on Interblink Interval, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016
53. Salvanos P, Tashbayev B, Chen X, Raeder S, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Utheim TP Clinical Findings in a Large Norwegian Cohort of Dry Eye Disease Based on Ocular Surface Staining, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016
54. Jackson C, Tashbayev B, Raeder S, Utheim TP, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Chen X: Correlation between Meibomian Gland Dysfunction and Age in a Norwegian Cohort of Dry Eye Patients, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016
55. Jackson C, Tashbayev B, Raeder S, Utheim TP, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Chen X: Tear Film Break-up Time as a Predictive Test Marker for Meibomian Gland Functionality and Dry Eye Severity Level in Patients with Meibomian Gland Dysfunction, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016
56. Badian R, Borgersen N, Utheim TP, Lagali N: Dendritic cell analysis in wide-field images of the sub-basal nerve plexus by in vivo confocal microscopy, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016
57. Landsend E, Tashbayev B, Chen X, Raeder S, Utheim OA, Stojanovic A, Lagali N, Dartt DA, Utheim TP: Clinical Findings in a Large Norwegian Cohort of Dry Eye Disease Based on Tear Film Break-up Time, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016
58. Chen X, Stojanovic A, Simonsen D, Wang X, Liang J, Hu D and Utheim TP: Corneal Epithelial Thickness Profile Change After Corneal Collagen Cross-linking with and without Epithelial Removal in Treatment of Keratoconus, Nordic Congress of Ophthalmology, Aarhus, Denmark, 2016
59. Khan A, Utheim TP, Reppe S, Olstad OK, Fostad I, Eidet JR: Proteomic Characterization of Human Retinal Pigment Epithelium Cultured With Sericin, 16 th EURETINA Congress, Copenhagen, Denmark, 2016
60. Jensen JL, Utheim OA, Chen X, Thiede B, Aqrawi L, Rusthen S, Young A, Utheim TP, Galtung HK: Searching for Disease Biomarkers for Primary Sjögren’s Syndrome Based on Oral and Ocular Patient Examinations, Biomarkers and Targeted Therapeutics in Sjögren’s (BATTS) Conference, Oklahoma, US, September 19-22, 2016
61. Eidet JR, Tashbayev B, Chen X, Ræder S, Badian R, Utheim OA, Fostad IG, Dartt DA, Utheim TP: Gender Differences in Dry Eye Disease, TFOS, September 7-10, 2016, in Montpellier, France
62. Eidet JR, Tashbayev B, Chen X, Ræder S, Badian R, Utheim OA, Fostad IG, Dartt DA, Utheim TP: Air Pollution and Dry Eye Disease in Norway, TFOS, September 7-10, 2016, in Montpellier, France
63. Lagali N, Wowra B, Utheim TP, Eden U, Wylegala E, Fagerholm P: Imaging limbal stem cell niche degradation and progression of aniridia related keratopathy in several patient cohorts, 3th European Aniridia Conference, Duisburg, Germany, 2016
64. Olstad OK, Raastad T, Reppe S, Gautvik VT, Kvernevik KJ, Utheim TP, Gautvik KM:
Postmenopausal osteoporosis is characterized by a distinct muscle transcription profile which can be markedly changed through heavy-load strength training; American Society for Bone and Mineral Research, Denver, September 8-11, 2017
65. Pedersen H, Hagen LA, Landsend ES, Gilson SJ, Gjelle J, Utheim OA, Utheim TP, Neitz M, Baraas R: Chromatic sensitivity in aniridia; 24th symposium of the International Colour Vision Society (ICVS), Erlangen, Germany, 2016
66. Pedersen H, Jon Gjelle VB,  Hagen LA, Landsend ES, Gilson S, Utheim OA, Utheim TP,  Baraas R: Refractive Errors and Ocular biometry in Aniridia. International Myopia Conference, Birmingham, UK, September 2017
67. Dartt DA, Botten N, Hodges RP, Li D, Bair A, Shatos M, Utheim TP; Serhan CN: RvD2 Increases Goblet Cell cAMP and Intracellular [Ca2+] to Regulate Mucin Secretion anMaintain Ocular Surface Homeostasis in Both Health and Disease; Bioactive Lipids Meeting, Puerto Vallarta, Mexico, October 22 - 25, 2017
68. Bair JA,  Olsen MV, Hodges RR,  Utheim TP, Serhan CN, Dartt DA: Comparison of signaling pathways used by the specialized pro-resolving mediators maresin1- and maresin-2 to regulate goblet cell function, The New York Academy of Sciences, New York, US, June 25 - June 26, 2018
69. Kosmina R, Utheim TP, Tønseth KA, Reppe S, Edin NF, Sandvik JA, Sehic A, Bergersen LH, Jackson CJ: Hypoxia Favors Maintenance of Undifferentiated Epidermal Cell Phenotype for Potential Treatment of Limbal Stem Cell Deficiency Following One-Week Storage/The Norwegian Society of Ophthalmology, Soria Moria, Oslo, Norway, 2017 (selected for oral presentration of abstract)
70. Landsend ES, Utheim TP: Analyses of the tear film in Aniridia/The Norwegian Society of Ophthalmology, Soria Moria, Oslo, Norway, 2017 (selected for oral presentration of abstract)
71. Botten N, Hodges RR, Li D, Bair JA, Shatos MA, Utheim TP, Serhan CN, Dartt DA:
Resolvin D2 Increases Mucin Secretion in Cultured Conjunctival Goblet Cells via the cAMP Signaling Pathway, Keystone Symposia, Royal Dublin Society, Dublin, Ireland, March 24 -28, 2018
72. Markus V. Olsen, Anne V. Lyngstadaas, Bair J, Hodges R, Utheim TP, Serhan CS, Dartt DA: Pro-resolving mediator maresin-1 regulates conjunctival goblet cell mucin secretion and tear film homeostasis, Keystone Symposia, Royal Dublin Society, Dublin, Ireland, March 24—28, 2018
73. Lyngstadaas AV, Olsen MV, Bair J, Hodges R, Utheim TP, Serhan CS, Dartt DA: The pro-resolving mediator Annexin A1 regulates MUC5AC secretion in cultured goblet cells suggesting a new use in inflammatory conjunctival diseases, Keystone Symposia, Royal Dublin Society, Dublin, Ireland, March 24—28, 2018
74. Lippestad M, Hodges R, Utheim TP, Serhan CS, Dartt DA: Signaling Pathways Used by Resolvin E1 to Increase Intracellular Ca2+ and Mucin Secretion in Conjunctival Goblet Cells, Keystone Symposia, Royal Dublin Society, Dublin, Ireland, March 24—28, 2018
75. Tashbayev B, Chen X, Utheim ØA, Rusthen S, Young A, Herlofson BB, Hove LH, Singh PB, Rykke M, Aqrawi LA, Utheim TP, Garen T, Palm Ø, Jensen JL: Primary Sjögren´s Syndrome and Non-Sjögren´s Sicca Syndrome Patients; unexpected differences in symptoms and findings of dry eye disease, dry mouth, and oral health related quality of life; 14th International Sjogren´s Syndrome Symposium, The Johns Hopkins University, Washington, DC
76. Utheim TP, Donnenfeld E, Holland E, Tauber J, Hamdani M, Shojaei A, Shire: Treatment of Dry Eye Disease with Lifitegrast Ophthalmic Solution 5.0%: Combined Efficacy and Safety from 5 Randomized Controlled Trials, Nordic Congress of Ophthalmology, August 22-26, 2018, Oslo, Norway
77. Malmin A, Utheim TP, Meberg KO, Forsaa VA: Endophthalmitis after cataract surgery; single-center series over 14 years, Nordic Congress of Ophthalmology, August 22-26, 2018, Oslo, Norway
78. Gautvik K, Günther GC, Yazdani M, Lindalen E, Valland H, Gautvik VT, Olstad OK, Holden M, Utheim TP, Reppe S: Distinct subsets of non-coding RNAs, including miRNAs, are associated with BMD in stressed and unstressed bone, The American Society of Bone and Mineral Research, Montréal, Québec, Canada, Sept 28 - Oct 1, 2018
79. Langeland Ø, Tashbayev B, Chen X, Utheim O, Young A, Herlofson BB, Rusthen S, Galtung H, Utheim TP, Jensen JL: Comparative Ocular and Oral Findings in Sicca Complex,
Nordic Congress of Ophthalmology, August 22-26, 2018, Oslo, Norway
80. Muhammed YA, Xiao J, Olafsson J, Chen X, Lagali N, Ræder S, Utheim OA, Dartt DA, Utheim TP: Meibomian Gland Morphology is a Sensitive Early Indicator of Meibomian Gland Dysfunction (submitted): Meibomian Gland Morphology is a Sensitive Early Indicator of Meibomian Gland Dysfunction, Nordic Congress of Ophthalmology, August 22-26, 2018, Oslo, Norway
81. Xiao J, Muhammed YA, Olafsson J, Chen X, Lagali N, Raeder S, Utheim OA, Dartt DA, Utheim TP: Development and Evaluation of A Novel Meiboscore for Meibography Analysis of Dry Eye Disease, Nordic Congress of Ophthalmology, August 22-26, 2018, Oslo, Norway
82. Muhammed YA, Xiao J, Kinsang, Utheim TP, Chen DF: Elevated Intraocular Pressure Causes Retinal Ganglion Cell Dysfunction and Triggers Glaucomatous Neuropathy, Nordic Congress of Ophthalmology, August 22-26, 2018, Oslo, Norway
83. Xiao J, Muhammed YA, Kinsang, Utheim TP, Chen DF: Evaluating the Retinal Function in Rhodopsin Knockout Mice with Quantification of Spatial Vision, Nordic Congress of Ophthalmology, August 22-26, 2018, Oslo, Norway
84. Haughom B, Lerum S, Utheim TP, Kinge B: Referrals from General Practitioners and Optometrists; how do they compare, Nordic Congress of Ophthalmology, August 22-26, 2018, Oslo, Norway
85. Khan A, Jackson CJ, Reppe S, Utheim TP, Olstad OK, Thiede B, Eidet JR:
Sericin-Induced Melanogenesis in Cultured Retinal Pigment Epithelium
is Associated with Elevated Levels of Hydrogen Peroxide, Nordic Congress of Ophthalmology, August 22-26, 2018, Oslo, Norway
86. Yang M, Lippestad M, Bair JA, Hodges RR, Utheim TP,  Serhan CN, Dartt DA: Use BLT1 Receptor to Increase [Ca2+]i and Mucin Secretion in Health and Block LTB4-stimulated Increase in [Ca2+]i in Disease, The New York Academy of Sciences, New York, US, June 25 - June 26, 2018
87. Tellefsen S, Badian R, Stojanovic A, Utheim TP, Utheim OA, Tashbayev B, Raeder S, Chen X: Gender Differences in Symptoms and Signs of Dry Eye Disease in a Norwegian Cohort of Patients (EVER 2018, accepted)
88. Utheim OA, Raeder S, Badian R, Chen X, Tashbayev B, Utheim TP:  Comparison of Ocular Surface Disease Index score and Clinical Dry Eye Disease Parameters in the Young (aged 0-19) and the Elderly (aged 80-99) (EVER 2018, accepted)
Publisert 2. okt. 2018 13:11 - Sist endret 13. nov. 2018 08:09